| ENSG00000177993.3 |
Bosutinib |
Bladder urothelial carcinoma |
0.026987783 |
Resistant |
| ENSG00000184274.3 |
Bosutinib |
Bladder urothelial carcinoma |
0.026887173 |
Resistant |
| ENSG00000184856.6 |
Bosutinib |
Bladder urothelial carcinoma |
0.012669176 |
Resistant |
| ENSG00000197934.4 |
Bosutinib |
Bladder urothelial carcinoma |
0.020972999 |
Resistant |
| ENSG00000223571.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.026923862 |
Resistant |
| ENSG00000225140.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.048709663 |
Resistant |
| ENSG00000225541.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.022616396 |
Resistant |
| ENSG00000225806.3 |
Bosutinib |
Bladder urothelial carcinoma |
0.02844583 |
Resistant |
| ENSG00000226312.3 |
Bosutinib |
Bladder urothelial carcinoma |
0.019341031 |
Resistant |
| ENSG00000227110.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.003317124 |
Resistant |
| ENSG00000228463.4 |
Bosutinib |
Bladder urothelial carcinoma |
0.016763775 |
Resistant |
| ENSG00000230105.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.040884064 |
Resistant |
| ENSG00000230550.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.040831503 |
Resistant |
| ENSG00000230825.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.012562266 |
Resistant |
| ENSG00000230925.3 |
Bosutinib |
Bladder urothelial carcinoma |
0.043443433 |
Resistant |
| ENSG00000231976.3 |
Bosutinib |
Bladder urothelial carcinoma |
0.003945108 |
Resistant |
| ENSG00000232298.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.007082684 |
Resistant |
| ENSG00000233215.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.001662606 |
Resistant |
| ENSG00000233384.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.039086974 |
Resistant |
| ENSG00000233895.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.022940351 |
Resistant |
| ENSG00000234772.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.045387805 |
Resistant |
| ENSG00000235072.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.003566094 |
Resistant |
| ENSG00000236212.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.025377931 |
Resistant |
| ENSG00000245904.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.044017624 |
Resistant |
| ENSG00000245928.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.021920658 |
Resistant |
| ENSG00000247934.3 |
Bosutinib |
Bladder urothelial carcinoma |
0.011931628 |
Resistant |
| ENSG00000248027.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.002996301 |
Resistant |
| ENSG00000250033.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.049288554 |
Resistant |
| ENSG00000251432.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.004224344 |
Resistant |
| ENSG00000253972.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.042639463 |
Resistant |
| ENSG00000254286.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.041992419 |
Resistant |
| ENSG00000255314.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.033442279 |
Resistant |
| ENSG00000255476.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.047147486 |
Resistant |
| ENSG00000257027.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.005251441 |
Resistant |
| ENSG00000257499.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.032037514 |
Resistant |
| ENSG00000257735.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.029596902 |
Resistant |
| ENSG00000258413.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.020773871 |
Resistant |
| ENSG00000258929.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.040535044 |
Resistant |
| ENSG00000258940.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.044321411 |
Resistant |
| ENSG00000259230.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.041797755 |
Resistant |
| ENSG00000260059.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.044360295 |
Resistant |
| ENSG00000260988.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.033305011 |
Resistant |
| ENSG00000260997.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.01372259 |
Resistant |
| ENSG00000261267.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.038695052 |
Resistant |
| ENSG00000261761.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.010202686 |
Resistant |
| ENSG00000267011.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.041965071 |
Resistant |
| ENSG00000267272.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.049384317 |
Resistant |
| ENSG00000267731.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.016692087 |
Resistant |
| ENSG00000268460.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.001080233 |
Resistant |
| ENSG00000269729.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.003227774 |
Resistant |
| ENSG00000269924.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.012638984 |
Resistant |
| ENSG00000271781.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.024059706 |
Resistant |
| ENSG00000272123.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.045710484 |
Resistant |
| ENSG00000272369.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.011212296 |
Resistant |
| ENSG00000272917.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.036171623 |
Resistant |
| ENSG00000273026.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.021611197 |
Resistant |
| ENSG00000197813.4 |
Bosutinib |
Breast invasive carcinoma |
0.046903536 |
Resistant |
| ENSG00000203362.2 |
Bosutinib |
Breast invasive carcinoma |
0.029398471 |
Resistant |
| ENSG00000227773.1 |
Bosutinib |
Breast invasive carcinoma |
0.015575592 |
Resistant |
| ENSG00000228201.1 |
Bosutinib |
Breast invasive carcinoma |
0.034077301 |
Resistant |
| ENSG00000228973.1 |
Bosutinib |
Breast invasive carcinoma |
0.042099856 |
Resistant |
| ENSG00000229739.1 |
Bosutinib |
Breast invasive carcinoma |
0.026591062 |
Resistant |
| ENSG00000232527.3 |
Bosutinib |
Breast invasive carcinoma |
0.011456729 |
Resistant |
| ENSG00000232978.2 |
Bosutinib |
Breast invasive carcinoma |
0.049485979 |
Resistant |
| ENSG00000233033.1 |
Bosutinib |
Breast invasive carcinoma |
0.04584689 |
Resistant |
| ENSG00000233785.1 |
Bosutinib |
Breast invasive carcinoma |
0.026862756 |
Resistant |
| ENSG00000234913.1 |
Bosutinib |
Breast invasive carcinoma |
0.011299999 |
Resistant |
| ENSG00000235445.1 |
Bosutinib |
Breast invasive carcinoma |
0.032609611 |
Resistant |
| ENSG00000235795.1 |
Bosutinib |
Breast invasive carcinoma |
0.011999181 |
Resistant |
| ENSG00000235843.1 |
Bosutinib |
Breast invasive carcinoma |
0.01914068 |
Resistant |
| ENSG00000237298.4 |
Bosutinib |
Breast invasive carcinoma |
0.033130594 |
Resistant |
| ENSG00000237726.1 |
Bosutinib |
Breast invasive carcinoma |
0.024481571 |
Resistant |
| ENSG00000239593.1 |
Bosutinib |
Breast invasive carcinoma |
0.033329059 |
Resistant |
| ENSG00000240291.1 |
Bosutinib |
Breast invasive carcinoma |
0.045008525 |
Resistant |
| ENSG00000244968.2 |
Bosutinib |
Breast invasive carcinoma |
0.03647772 |
Resistant |
| ENSG00000246090.2 |
Bosutinib |
Breast invasive carcinoma |
0.028458607 |
Resistant |
| ENSG00000246792.2 |
Bosutinib |
Breast invasive carcinoma |
0.034261718 |
Resistant |
| ENSG00000247877.2 |
Bosutinib |
Breast invasive carcinoma |
0.04567796 |
Resistant |
| ENSG00000249249.1 |
Bosutinib |
Breast invasive carcinoma |
0.045507898 |
Resistant |
| ENSG00000250057.1 |
Bosutinib |
Breast invasive carcinoma |
0.046338872 |
Resistant |
| ENSG00000253549.1 |
Bosutinib |
Breast invasive carcinoma |
0.044527244 |
Resistant |
| ENSG00000253562.1 |
Bosutinib |
Breast invasive carcinoma |
0.012782045 |
Resistant |
| ENSG00000253708.1 |
Bosutinib |
Breast invasive carcinoma |
0.042161269 |
Resistant |
| ENSG00000254205.1 |
Bosutinib |
Breast invasive carcinoma |
0.020782473 |
Resistant |
| ENSG00000255125.1 |
Bosutinib |
Breast invasive carcinoma |
0.043080866 |
Resistant |
| ENSG00000257264.2 |
Bosutinib |
Breast invasive carcinoma |
0.017639863 |
Resistant |
| ENSG00000257381.2 |
Bosutinib |
Breast invasive carcinoma |
0.02904448 |
Resistant |
| ENSG00000257527.1 |
Bosutinib |
Breast invasive carcinoma |
0.02274017 |
Resistant |
| ENSG00000259039.1 |
Bosutinib |
Breast invasive carcinoma |
0.026747611 |
Resistant |
| ENSG00000259327.1 |
Bosutinib |
Breast invasive carcinoma |
0.026992177 |
Resistant |
| ENSG00000259736.1 |
Bosutinib |
Breast invasive carcinoma |
0.011074744 |
Resistant |
| ENSG00000259782.2 |
Bosutinib |
Breast invasive carcinoma |
0.040517818 |
Resistant |
| ENSG00000260063.1 |
Bosutinib |
Breast invasive carcinoma |
0.017467107 |
Resistant |
| ENSG00000260808.1 |
Bosutinib |
Breast invasive carcinoma |
0.021742688 |
Resistant |
| ENSG00000260955.2 |
Bosutinib |
Breast invasive carcinoma |
0.044689121 |
Resistant |
| ENSG00000261083.1 |
Bosutinib |
Breast invasive carcinoma |
0.015919077 |
Resistant |
| ENSG00000261399.1 |
Bosutinib |
Breast invasive carcinoma |
0.013211913 |
Resistant |
| ENSG00000261533.1 |
Bosutinib |
Breast invasive carcinoma |
0.043812123 |
Resistant |
| ENSG00000261662.1 |
Bosutinib |
Breast invasive carcinoma |
0.013225047 |
Resistant |
| ENSG00000261775.1 |
Bosutinib |
Breast invasive carcinoma |
0.026795217 |
Resistant |
| ENSG00000262380.1 |
Bosutinib |
Breast invasive carcinoma |
0.049110748 |
Resistant |
| ENSG00000264940.2 |
Bosutinib |
Breast invasive carcinoma |
0.048897537 |
Resistant |
| ENSG00000265008.1 |
Bosutinib |
Breast invasive carcinoma |
0.047991129 |
Resistant |
| ENSG00000266601.1 |
Bosutinib |
Breast invasive carcinoma |
0.041221007 |
Resistant |
| ENSG00000266821.1 |
Bosutinib |
Breast invasive carcinoma |
0.033352618 |
Resistant |
| ENSG00000267167.1 |
Bosutinib |
Breast invasive carcinoma |
0.039978849 |
Resistant |
| ENSG00000267501.1 |
Bosutinib |
Breast invasive carcinoma |
0.032354974 |
Resistant |
| ENSG00000267764.1 |
Bosutinib |
Breast invasive carcinoma |
0.02411076 |
Resistant |
| ENSG00000267898.1 |
Bosutinib |
Breast invasive carcinoma |
0.016245648 |
Resistant |
| ENSG00000268573.1 |
Bosutinib |
Breast invasive carcinoma |
0.036618801 |
Resistant |
| ENSG00000271204.1 |
Bosutinib |
Breast invasive carcinoma |
0.038894086 |
Resistant |
| ENSG00000271849.1 |
Bosutinib |
Breast invasive carcinoma |
0.023109851 |
Resistant |
| ENSG00000272264.1 |
Bosutinib |
Breast invasive carcinoma |
0.047501433 |
Resistant |
| ENSG00000272377.1 |
Bosutinib |
Breast invasive carcinoma |
0.049672492 |
Resistant |
| ENSG00000272914.1 |
Bosutinib |
Breast invasive carcinoma |
0.040619716 |
Resistant |
| ENSG00000273056.1 |
Bosutinib |
Breast invasive carcinoma |
0.01566356 |
Resistant |
| ENSG00000273175.1 |
Bosutinib |
Breast invasive carcinoma |
0.025361482 |
Resistant |
| ENSG00000273342.1 |
Bosutinib |
Breast invasive carcinoma |
0.035432425 |
Resistant |
| ENSG00000118412.8 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024005682 |
Resistant |
| ENSG00000186019.10 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039146436 |
Resistant |
| ENSG00000196668.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032904398 |
Resistant |
| ENSG00000204625.6 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025430989 |
Resistant |
| ENSG00000214650.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021466232 |
Resistant |
| ENSG00000214770.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03123155 |
Resistant |
| ENSG00000224043.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001467074 |
Resistant |
| ENSG00000224086.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036681808 |
Resistant |
| ENSG00000224635.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027278238 |
Resistant |
| ENSG00000225981.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043810985 |
Resistant |
| ENSG00000226574.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02576875 |
Resistant |
| ENSG00000226851.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044482355 |
Resistant |
| ENSG00000227071.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048491408 |
Resistant |
| ENSG00000227252.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030086304 |
Resistant |
| ENSG00000227704.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.012754319 |
Resistant |
| ENSG00000228203.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.010744073 |
Resistant |
| ENSG00000228878.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041978694 |
Resistant |
| ENSG00000229127.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036236314 |
Resistant |
| ENSG00000229645.4 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036041038 |
Resistant |
| ENSG00000229839.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.006014434 |
Resistant |
| ENSG00000229950.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024480288 |
Resistant |
| ENSG00000231305.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031453107 |
Resistant |
| ENSG00000231595.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046193972 |
Resistant |
| ENSG00000231651.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041290561 |
Resistant |
| ENSG00000231704.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04548204 |
Resistant |
| ENSG00000231976.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003612927 |
Resistant |
| ENSG00000232640.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005562272 |
Resistant |
| ENSG00000232940.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028187083 |
Resistant |
| ENSG00000234129.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040491332 |
Resistant |
| ENSG00000234134.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026203354 |
Resistant |
| ENSG00000234818.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007718099 |
Resistant |
| ENSG00000234917.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000698093 |
Resistant |
| ENSG00000234998.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037282037 |
Resistant |
| ENSG00000235033.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022208545 |
Resistant |
| ENSG00000235092.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.010528859 |
Resistant |
| ENSG00000235121.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015196608 |
Resistant |
| ENSG00000235586.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04835826 |
Resistant |
| ENSG00000235643.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033325624 |
Resistant |
| ENSG00000235664.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041955118 |
Resistant |
| ENSG00000236206.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028718091 |
Resistant |
| ENSG00000236472.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025883732 |
Resistant |
| ENSG00000236772.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003323698 |
Resistant |
| ENSG00000244268.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.029247602 |
Resistant |
| ENSG00000244380.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007328432 |
Resistant |
| ENSG00000246465.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030227784 |
Resistant |
| ENSG00000246731.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004956461 |
Resistant |
| ENSG00000247679.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042331536 |
Resistant |
| ENSG00000248275.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013651357 |
Resistant |
| ENSG00000248664.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041510746 |
Resistant |
| ENSG00000248714.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015039602 |
Resistant |
| ENSG00000248925.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037092315 |
Resistant |
| ENSG00000250802.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043060319 |
Resistant |
| ENSG00000253355.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005011085 |
Resistant |
| ENSG00000254207.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035026421 |
Resistant |
| ENSG00000254224.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032650718 |
Resistant |
| ENSG00000255471.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044958118 |
Resistant |
| ENSG00000255651.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013395256 |
Resistant |
| ENSG00000257381.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027066329 |
Resistant |
| ENSG00000258345.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021735594 |
Resistant |
| ENSG00000258450.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038342403 |
Resistant |
| ENSG00000259416.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031988291 |
Resistant |
| ENSG00000259818.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016878706 |
Resistant |
| ENSG00000260008.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03810366 |
Resistant |
| ENSG00000260060.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039509891 |
Resistant |
| ENSG00000260091.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023166389 |
Resistant |
| ENSG00000260515.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008705637 |
Resistant |
| ENSG00000260572.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035983044 |
Resistant |
| ENSG00000260645.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009882915 |
Resistant |
| ENSG00000260647.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.047205121 |
Resistant |
| ENSG00000261019.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009497319 |
Resistant |
| ENSG00000261357.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035110956 |
Resistant |
| ENSG00000261758.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014864885 |
Resistant |
| ENSG00000263214.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017233221 |
Resistant |
| ENSG00000264885.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007157 |
Resistant |
| ENSG00000265511.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031461637 |
Resistant |
| ENSG00000266601.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.019676387 |
Resistant |
| ENSG00000266903.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028726367 |
Resistant |
| ENSG00000266935.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015786749 |
Resistant |
| ENSG00000266994.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033558389 |
Resistant |
| ENSG00000267064.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.0226352 |
Resistant |
| ENSG00000267381.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021389513 |
Resistant |
| ENSG00000267560.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013862702 |
Resistant |
| ENSG00000267747.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003651852 |
Resistant |
| ENSG00000268230.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022639926 |
Resistant |
| ENSG00000268895.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.010845869 |
Resistant |
| ENSG00000270820.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026584287 |
Resistant |
| ENSG00000271200.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021300639 |
Resistant |
| ENSG00000271998.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002994782 |
Resistant |
| ENSG00000272003.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.018159601 |
Resistant |
| ENSG00000272029.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.029482214 |
Resistant |
| ENSG00000272077.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048593033 |
Resistant |
| ENSG00000272248.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040060275 |
Resistant |
| ENSG00000272370.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.006904648 |
Resistant |
| ENSG00000272662.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046052946 |
Resistant |
| ENSG00000272667.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036512163 |
Resistant |
| ENSG00000272682.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036061991 |
Resistant |
| ENSG00000273454.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002676086 |
Resistant |
| ENSG00000203280.3 |
Bosutinib |
Colon adenocarcinoma |
0.009070151 |
Resistant |
| ENSG00000226047.1 |
Bosutinib |
Colon adenocarcinoma |
0.007896547 |
Resistant |
| ENSG00000227726.1 |
Bosutinib |
Colon adenocarcinoma |
0.024772964 |
Resistant |
| ENSG00000230825.1 |
Bosutinib |
Colon adenocarcinoma |
0.04025578 |
Resistant |
| ENSG00000231407.1 |
Bosutinib |
Colon adenocarcinoma |
0.045985045 |
Resistant |
| ENSG00000232388.2 |
Bosutinib |
Colon adenocarcinoma |
0.026906015 |
Resistant |
| ENSG00000235123.1 |
Bosutinib |
Colon adenocarcinoma |
0.047188866 |
Resistant |
| ENSG00000235488.1 |
Bosutinib |
Colon adenocarcinoma |
0.04882007 |
Resistant |
| ENSG00000236206.1 |
Bosutinib |
Colon adenocarcinoma |
0.048155593 |
Resistant |
| ENSG00000237017.1 |
Bosutinib |
Colon adenocarcinoma |
0.009774094 |
Resistant |
| ENSG00000245954.2 |
Bosutinib |
Colon adenocarcinoma |
0.030409054 |
Resistant |
| ENSG00000250786.1 |
Bosutinib |
Colon adenocarcinoma |
0.004300663 |
Resistant |
| ENSG00000254968.2 |
Bosutinib |
Colon adenocarcinoma |
0.035010668 |
Resistant |
| ENSG00000255507.1 |
Bosutinib |
Colon adenocarcinoma |
0.023993178 |
Resistant |
| ENSG00000257894.1 |
Bosutinib |
Colon adenocarcinoma |
0.037503825 |
Resistant |
| ENSG00000261729.1 |
Bosutinib |
Colon adenocarcinoma |
0.036760171 |
Resistant |
| ENSG00000261888.1 |
Bosutinib |
Colon adenocarcinoma |
0.012773795 |
Resistant |
| ENSG00000266844.1 |
Bosutinib |
Colon adenocarcinoma |
0.046333576 |
Resistant |
| ENSG00000267018.1 |
Bosutinib |
Colon adenocarcinoma |
0.012872165 |
Resistant |
| ENSG00000267183.1 |
Bosutinib |
Colon adenocarcinoma |
0.024080126 |
Resistant |
| ENSG00000267230.1 |
Bosutinib |
Colon adenocarcinoma |
0.002499554 |
Resistant |
| ENSG00000267575.2 |
Bosutinib |
Colon adenocarcinoma |
0.024398691 |
Resistant |
| ENSG00000269574.1 |
Bosutinib |
Colon adenocarcinoma |
0.005340145 |
Resistant |
| ENSG00000270068.1 |
Bosutinib |
Colon adenocarcinoma |
0.041820848 |
Resistant |
| ENSG00000272635.1 |
Bosutinib |
Colon adenocarcinoma |
0.036690693 |
Resistant |
| ENSG00000273174.1 |
Bosutinib |
Colon adenocarcinoma |
0.00753997 |
Resistant |
| ENSG00000152487.6 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046458525 |
Resistant |
| ENSG00000178440.5 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021093372 |
Resistant |
| ENSG00000180139.10 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015370278 |
Resistant |
| ENSG00000184068.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023323568 |
Resistant |
| ENSG00000203327.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031078897 |
Resistant |
| ENSG00000203875.6 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029884693 |
Resistant |
| ENSG00000206140.5 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000932622 |
Resistant |
| ENSG00000206176.5 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033445467 |
Resistant |
| ENSG00000212552.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032167021 |
Resistant |
| ENSG00000215159.3 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026032541 |
Resistant |
| ENSG00000223461.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002637819 |
Resistant |
| ENSG00000223598.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01824399 |
Resistant |
| ENSG00000224738.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035896882 |
Resistant |
| ENSG00000225187.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012049776 |
Resistant |
| ENSG00000225484.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034682757 |
Resistant |
| ENSG00000225675.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010116277 |
Resistant |
| ENSG00000225792.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035201742 |
Resistant |
| ENSG00000225880.4 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03405725 |
Resistant |
| ENSG00000226381.3 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03074396 |
Resistant |
| ENSG00000227161.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042517063 |
Resistant |
| ENSG00000227492.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008714412 |
Resistant |
| ENSG00000228107.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040659545 |
Resistant |
| ENSG00000228444.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034920087 |
Resistant |
| ENSG00000228677.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018286113 |
Resistant |
| ENSG00000228801.5 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034129102 |
Resistant |
| ENSG00000229832.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016196487 |
Resistant |
| ENSG00000230010.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026885252 |
Resistant |
| ENSG00000230424.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013987199 |
Resistant |
| ENSG00000231104.4 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005978827 |
Resistant |
| ENSG00000231595.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032837858 |
Resistant |
| ENSG00000234327.3 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039432576 |
Resistant |
| ENSG00000234509.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014171684 |
Resistant |
| ENSG00000234945.3 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028594539 |
Resistant |
| ENSG00000235381.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011188207 |
Resistant |
| ENSG00000235560.3 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015344195 |
Resistant |
| ENSG00000235843.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019814177 |
Resistant |
| ENSG00000235908.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025815304 |
Resistant |
| ENSG00000235919.3 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037700619 |
Resistant |
| ENSG00000236200.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031941634 |
Resistant |
| ENSG00000236308.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038974469 |
Resistant |
| ENSG00000236463.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017956084 |
Resistant |
| ENSG00000236953.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039638569 |
Resistant |
| ENSG00000236991.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037488414 |
Resistant |
| ENSG00000237054.5 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04340639 |
Resistant |
| ENSG00000237489.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024815655 |
Resistant |
| ENSG00000238140.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038433665 |
Resistant |
| ENSG00000238198.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046717593 |
Resistant |
| ENSG00000240758.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008571009 |
Resistant |
| ENSG00000242553.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038290801 |
Resistant |
| ENSG00000244184.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00056258 |
Resistant |
| ENSG00000247092.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006541215 |
Resistant |
| ENSG00000248367.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020588644 |
Resistant |
| ENSG00000248559.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025021685 |
Resistant |
| ENSG00000250950.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022402116 |
Resistant |
| ENSG00000251323.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04656942 |
Resistant |
| ENSG00000253174.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004981222 |
Resistant |
| ENSG00000254208.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02332014 |
Resistant |
| ENSG00000254427.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030734719 |
Resistant |
| ENSG00000254907.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011837946 |
Resistant |
| ENSG00000254985.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024246461 |
Resistant |
| ENSG00000255421.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000807823 |
Resistant |
| ENSG00000255449.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007452407 |
Resistant |
| ENSG00000256124.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026182453 |
Resistant |
| ENSG00000256862.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014572413 |
Resistant |
| ENSG00000258099.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039033822 |
Resistant |
| ENSG00000258442.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024245331 |
Resistant |
| ENSG00000259172.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002371987 |
Resistant |
| ENSG00000260488.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042735425 |
Resistant |
| ENSG00000260589.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035372258 |
Resistant |
| ENSG00000260664.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04001684 |
Resistant |
| ENSG00000260708.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049578453 |
Resistant |
| ENSG00000260920.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038214618 |
Resistant |
| ENSG00000260924.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014203182 |
Resistant |
| ENSG00000261326.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015702149 |
Resistant |
| ENSG00000261864.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037337182 |
Resistant |
| ENSG00000262777.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017402279 |
Resistant |
| ENSG00000263272.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025406942 |
Resistant |
| ENSG00000264860.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009478542 |
Resistant |
| ENSG00000264920.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034064831 |
Resistant |
| ENSG00000265342.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040195311 |
Resistant |
| ENSG00000266289.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017224 |
Resistant |
| ENSG00000266473.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031885725 |
Resistant |
| ENSG00000266821.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032189243 |
Resistant |
| ENSG00000267274.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006259608 |
Resistant |
| ENSG00000267289.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045931815 |
Resistant |
| ENSG00000267419.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044917866 |
Resistant |
| ENSG00000267787.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045404741 |
Resistant |
| ENSG00000268093.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040571978 |
Resistant |
| ENSG00000268649.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004405757 |
Resistant |
| ENSG00000269293.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041718737 |
Resistant |
| ENSG00000269534.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015555468 |
Resistant |
| ENSG00000269609.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004818685 |
Resistant |
| ENSG00000269942.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045066225 |
Resistant |
| ENSG00000269947.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041742485 |
Resistant |
| ENSG00000269954.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008848746 |
Resistant |
| ENSG00000270019.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008951358 |
Resistant |
| ENSG00000270062.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019739408 |
Resistant |
| ENSG00000270068.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024682845 |
Resistant |
| ENSG00000270165.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012400385 |
Resistant |
| ENSG00000270195.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008628791 |
Resistant |
| ENSG00000270599.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049442188 |
Resistant |
| ENSG00000271821.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043108915 |
Resistant |
| ENSG00000271855.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009690947 |
Resistant |
| ENSG00000271856.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039612275 |
Resistant |
| ENSG00000272053.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048252544 |
Resistant |
| ENSG00000272093.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03440243 |
Resistant |
| ENSG00000272216.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033573109 |
Resistant |
| ENSG00000272254.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048017485 |
Resistant |
| ENSG00000272288.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000727135 |
Resistant |
| ENSG00000272365.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004971763 |
Resistant |
| ENSG00000272662.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002178477 |
Resistant |
| ENSG00000272716.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004428587 |
Resistant |
| ENSG00000272853.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002695032 |
Resistant |
| ENSG00000273061.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020508618 |
Resistant |
| ENSG00000273162.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01221157 |
Resistant |
| ENSG00000273181.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00606764 |
Resistant |
| ENSG00000273306.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039102517 |
Resistant |
| ENSG00000273424.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049862457 |
Resistant |
| ENSG00000206142.5 |
Bosutinib |
Esophageal cancer |
0.024939485 |
Resistant |
| ENSG00000223414.2 |
Bosutinib |
Esophageal cancer |
0.030613522 |
Resistant |
| ENSG00000238140.1 |
Bosutinib |
Esophageal cancer |
0.023447512 |
Resistant |
| ENSG00000269924.1 |
Bosutinib |
Esophageal cancer |
0.017503447 |
Resistant |
| ENSG00000125804.9 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.002161063 |
Resistant |
| ENSG00000131484.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.000328526 |
Resistant |
| ENSG00000180846.4 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.032368837 |
Resistant |
| ENSG00000203875.6 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.043633681 |
Resistant |
| ENSG00000215458.4 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.026239647 |
Resistant |
| ENSG00000223374.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.035821218 |
Resistant |
| ENSG00000223573.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.023763536 |
Resistant |
| ENSG00000225218.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.045928242 |
Resistant |
| ENSG00000225331.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.025001676 |
Resistant |
| ENSG00000226803.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.038165736 |
Resistant |
| ENSG00000227637.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.015637931 |
Resistant |
| ENSG00000228839.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.046679008 |
Resistant |
| ENSG00000229591.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.023028403 |
Resistant |
| ENSG00000230439.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.00354168 |
Resistant |
| ENSG00000230806.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.044465969 |
Resistant |
| ENSG00000230844.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.016909074 |
Resistant |
| ENSG00000231628.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.026124813 |
Resistant |
| ENSG00000231731.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.013127848 |
Resistant |
| ENSG00000233330.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.028002772 |
Resistant |
| ENSG00000233799.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.035767906 |
Resistant |
| ENSG00000234245.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.000455028 |
Resistant |
| ENSG00000234477.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.046486798 |
Resistant |
| ENSG00000234630.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.029007209 |
Resistant |
| ENSG00000235192.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.027435244 |
Resistant |
| ENSG00000235760.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.021449202 |
Resistant |
| ENSG00000236194.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.022995253 |
Resistant |
| ENSG00000236472.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.009917002 |
Resistant |
| ENSG00000237399.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.010380951 |
Resistant |
| ENSG00000240291.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.019195311 |
Resistant |
| ENSG00000245275.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.041354968 |
Resistant |
| ENSG00000246889.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.034017546 |
Resistant |
| ENSG00000247982.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.029454494 |
Resistant |
| ENSG00000249234.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.026866498 |
Resistant |
| ENSG00000249593.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.019852898 |
Resistant |
| ENSG00000250081.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.035773753 |
Resistant |
| ENSG00000250764.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.036312765 |
Resistant |
| ENSG00000250950.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.034685936 |
Resistant |
| ENSG00000253121.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.013606409 |
Resistant |
| ENSG00000255148.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.00039015 |
Resistant |
| ENSG00000255334.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.013971316 |
Resistant |
| ENSG00000255503.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.044972046 |
Resistant |
| ENSG00000256448.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.002122875 |
Resistant |
| ENSG00000258044.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.011663803 |
Resistant |
| ENSG00000258086.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.038422514 |
Resistant |
| ENSG00000258946.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.011108016 |
Resistant |
| ENSG00000259125.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.020703439 |
Resistant |
| ENSG00000259212.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.022701061 |
Resistant |
| ENSG00000259595.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.044766193 |
Resistant |
| ENSG00000260948.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.009037683 |
Resistant |
| ENSG00000261231.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.029186133 |
Resistant |
| ENSG00000261529.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.006748567 |
Resistant |
| ENSG00000261712.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.048010496 |
Resistant |
| ENSG00000262380.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.016503352 |
Resistant |
| ENSG00000263923.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.022580273 |
Resistant |
| ENSG00000264083.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.022632017 |
Resistant |
| ENSG00000267251.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.030831192 |
Resistant |
| ENSG00000267395.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.036704779 |
Resistant |
| ENSG00000267605.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.013453887 |
Resistant |
| ENSG00000268061.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.032568305 |
Resistant |
| ENSG00000268564.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.015025699 |
Resistant |
| ENSG00000268583.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.030960162 |
Resistant |
| ENSG00000269148.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.005822059 |
Resistant |
| ENSG00000269737.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.020428402 |
Resistant |
| ENSG00000269825.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.023810728 |
Resistant |
| ENSG00000269894.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.039835428 |
Resistant |
| ENSG00000270041.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.048766474 |
Resistant |
| ENSG00000270083.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.042236898 |
Resistant |
| ENSG00000270108.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.043553685 |
Resistant |
| ENSG00000270189.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.021692519 |
Resistant |
| ENSG00000271398.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.033620257 |
Resistant |
| ENSG00000271843.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.04563485 |
Resistant |
| ENSG00000272033.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.032735959 |
Resistant |
| ENSG00000272216.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.02332366 |
Resistant |
| ENSG00000272255.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.035008643 |
Resistant |
| ENSG00000272983.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.046301319 |
Resistant |
| ENSG00000273007.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.017093038 |
Resistant |
| ENSG00000273139.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.043191612 |
Resistant |
| ENSG00000273188.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.044092563 |
Resistant |
| ENSG00000118412.8 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.0388601 |
Resistant |
| ENSG00000160336.10 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.002394175 |
Resistant |
| ENSG00000203327.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.017869007 |
Resistant |
| ENSG00000203441.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.03458014 |
Resistant |
| ENSG00000204380.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.008044942 |
Resistant |
| ENSG00000205424.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.030521054 |
Resistant |
| ENSG00000214347.5 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.026206341 |
Resistant |
| ENSG00000223477.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.042982088 |
Resistant |
| ENSG00000223695.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.000721111 |
Resistant |
| ENSG00000223701.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.044572751 |
Resistant |
| ENSG00000223749.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.033411834 |
Resistant |
| ENSG00000224086.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.04349844 |
Resistant |
| ENSG00000224142.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.048079895 |
Resistant |
| ENSG00000224292.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.007463008 |
Resistant |
| ENSG00000224614.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.029457544 |
Resistant |
| ENSG00000224638.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.035763405 |
Resistant |
| ENSG00000224707.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.03980849 |
Resistant |
| ENSG00000225075.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.01251479 |
Resistant |
| ENSG00000225205.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.049864169 |
Resistant |
| ENSG00000225493.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.023260007 |
Resistant |
| ENSG00000225822.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.040015879 |
Resistant |
| ENSG00000225891.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.017326639 |
Resistant |
| ENSG00000225945.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.032147814 |
Resistant |
| ENSG00000226310.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.03278584 |
Resistant |
| ENSG00000226312.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.040647857 |
Resistant |
| ENSG00000226330.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.020383002 |
Resistant |
| ENSG00000226352.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.035127552 |
Resistant |
| ENSG00000226676.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.047585631 |
Resistant |
| ENSG00000227409.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.002680375 |
Resistant |
| ENSG00000227496.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.018719731 |
Resistant |
| ENSG00000227527.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.045397953 |
Resistant |
| ENSG00000227673.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.038454696 |
Resistant |
| ENSG00000227698.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.032614384 |
Resistant |
| ENSG00000227885.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.027687487 |
Resistant |
| ENSG00000228317.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.022295753 |
Resistant |
| ENSG00000228386.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.017615903 |
Resistant |
| ENSG00000228486.5 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.004627802 |
Resistant |
| ENSG00000228509.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.024675579 |
Resistant |
| ENSG00000228614.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.040782681 |
Resistant |
| ENSG00000228737.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.003453502 |
Resistant |
| ENSG00000228917.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.042368073 |
Resistant |
| ENSG00000229582.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.046923221 |
Resistant |
| ENSG00000229780.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.000420272 |
Resistant |
| ENSG00000230102.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.047861325 |
Resistant |
| ENSG00000230174.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.013307376 |
Resistant |
| ENSG00000230303.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.01071317 |
Resistant |
| ENSG00000230489.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.020954072 |
Resistant |
| ENSG00000231024.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.041520406 |
Resistant |
| ENSG00000231563.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.014517216 |
Resistant |
| ENSG00000231607.4 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.000412084 |
Resistant |
| ENSG00000232487.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.032626582 |
Resistant |
| ENSG00000232613.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.04639012 |
Resistant |
| ENSG00000232719.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.030554127 |
Resistant |
| ENSG00000232788.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.045184453 |
Resistant |
| ENSG00000232803.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.019442809 |
Resistant |
| ENSG00000232860.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.021815213 |
Resistant |
| ENSG00000233013.4 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.012368107 |
Resistant |
| ENSG00000233178.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.005974057 |
Resistant |
| ENSG00000233547.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.026977035 |
Resistant |
| ENSG00000233775.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.046320887 |
Resistant |
| ENSG00000233799.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.010316057 |
Resistant |
| ENSG00000233806.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.037295839 |
Resistant |
| ENSG00000233862.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.019012568 |
Resistant |
| ENSG00000234915.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.013216395 |
Resistant |
| ENSG00000234945.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.014651637 |
Resistant |
| ENSG00000235078.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.047135232 |
Resistant |
| ENSG00000235257.4 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.024010829 |
Resistant |
| ENSG00000235262.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.002521254 |
Resistant |
| ENSG00000235373.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.012617378 |
Resistant |
| ENSG00000235423.4 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.0499711 |
Resistant |
| ENSG00000236051.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.028467141 |
Resistant |
| ENSG00000236383.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.033474423 |
Resistant |
| ENSG00000236519.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.032426073 |
Resistant |
| ENSG00000236772.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.043488846 |
Resistant |
| ENSG00000237054.5 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.02881044 |
Resistant |
| ENSG00000237073.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.045478283 |
Resistant |
| ENSG00000237331.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.009549243 |
Resistant |
| ENSG00000237576.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.040410134 |
Resistant |
| ENSG00000237737.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.041049884 |
Resistant |
| ENSG00000237756.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.03750683 |
Resistant |
| ENSG00000238039.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.043517167 |
Resistant |
| ENSG00000238123.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.016253317 |
Resistant |
| ENSG00000238141.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.019034354 |
Resistant |
| ENSG00000238197.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.043937119 |
Resistant |
| ENSG00000239407.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.00114896 |
Resistant |
| ENSG00000239705.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.017909033 |
Resistant |
| ENSG00000239906.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.026479505 |
Resistant |
| ENSG00000240143.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.037770314 |
Resistant |
| ENSG00000240618.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.004036498 |
Resistant |
| ENSG00000240996.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.038418928 |
Resistant |
| ENSG00000241042.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.045379792 |
Resistant |
| ENSG00000241860.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.008640861 |
Resistant |
| ENSG00000243176.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.020063123 |
Resistant |
| ENSG00000243230.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.019066389 |
Resistant |
| ENSG00000245534.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.000334305 |
Resistant |
| ENSG00000245667.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.013355383 |
Resistant |
| ENSG00000246323.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.037018985 |
Resistant |
| ENSG00000246859.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.016851471 |
Resistant |
| ENSG00000247151.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.036452307 |
Resistant |
| ENSG00000247373.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.033914481 |
Resistant |
| ENSG00000248416.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.00776082 |
Resistant |
| ENSG00000248677.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.014306203 |
Resistant |
| ENSG00000248790.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.011631857 |
Resistant |
| ENSG00000249786.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.00164832 |
Resistant |
| ENSG00000250132.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.031247061 |
Resistant |
| ENSG00000253730.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.017451426 |
Resistant |
| ENSG00000253921.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.026663322 |
Resistant |
| ENSG00000254900.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.012969982 |
Resistant |
| ENSG00000255142.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.004066273 |
Resistant |
| ENSG00000255160.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.029207733 |
Resistant |
| ENSG00000255651.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.016467997 |
Resistant |
| ENSG00000255893.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.000684936 |
Resistant |
| ENSG00000255966.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.012834627 |
Resistant |
| ENSG00000256006.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.044964628 |
Resistant |
| ENSG00000256092.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.015284201 |
Resistant |
| ENSG00000256150.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.042520997 |
Resistant |
| ENSG00000257329.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.030858336 |
Resistant |
| ENSG00000257702.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.024624567 |
Resistant |
| ENSG00000257808.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.030729891 |
Resistant |
| ENSG00000258101.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.045014171 |
Resistant |
| ENSG00000258693.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.049685846 |
Resistant |
| ENSG00000258730.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.038554937 |
Resistant |
| ENSG00000258821.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.015928459 |
Resistant |
| ENSG00000259398.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.046225442 |
Resistant |
| ENSG00000259717.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.03364389 |
Resistant |
| ENSG00000259783.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.02231661 |
Resistant |
| ENSG00000260101.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.017591461 |
Resistant |
| ENSG00000260167.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.009879372 |
Resistant |
| ENSG00000260194.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.046857189 |
Resistant |
| ENSG00000260249.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.049889247 |
Resistant |
| ENSG00000260672.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.043769773 |
Resistant |
| ENSG00000260796.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.009382647 |
Resistant |
| ENSG00000260808.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.02737042 |
Resistant |
| ENSG00000260874.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.040793878 |
Resistant |
| ENSG00000260932.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.015195087 |
Resistant |
| ENSG00000260989.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.042032663 |
Resistant |
| ENSG00000261172.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.047055251 |
Resistant |
| ENSG00000261266.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.04437375 |
Resistant |
| ENSG00000261318.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.039432677 |
Resistant |
| ENSG00000261386.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.015752999 |
Resistant |
| ENSG00000261396.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.027282697 |
Resistant |
| ENSG00000261695.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.0200353 |
Resistant |
| ENSG00000261823.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.013682154 |
Resistant |
| ENSG00000261840.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.006001459 |
Resistant |
| ENSG00000263370.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.033252743 |
Resistant |
| ENSG00000263627.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.014635373 |
Resistant |
| ENSG00000263916.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.011311844 |
Resistant |
| ENSG00000264107.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.005874864 |
Resistant |
| ENSG00000264448.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.042616129 |
Resistant |
| ENSG00000264520.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.033545477 |
Resistant |
| ENSG00000265451.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.049193443 |
Resistant |
| ENSG00000265496.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.00846821 |
Resistant |
| ENSG00000266049.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.042074173 |
Resistant |
| ENSG00000266900.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.037496998 |
Resistant |
| ENSG00000266912.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.000836018 |
Resistant |
| ENSG00000266921.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.014662848 |
Resistant |
| ENSG00000266994.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.028615885 |
Resistant |
| ENSG00000267018.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.001807254 |
Resistant |
| ENSG00000267063.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.011147768 |
Resistant |
| ENSG00000267183.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.003752395 |
Resistant |
| ENSG00000267230.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.049872432 |
Resistant |
| ENSG00000267344.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.037254163 |
Resistant |
| ENSG00000267348.2 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.004802769 |
Resistant |
| ENSG00000268047.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.047038846 |
Resistant |
| ENSG00000268095.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.019281025 |
Resistant |
| ENSG00000268392.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.002780563 |
Resistant |
| ENSG00000268583.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.008173887 |
Resistant |
| ENSG00000268970.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.006115675 |
Resistant |
| ENSG00000269066.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.00546097 |
Resistant |
| ENSG00000269836.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.01899652 |
Resistant |
| ENSG00000269938.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.011486776 |
Resistant |
| ENSG00000270061.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.016484504 |
Resistant |
| ENSG00000270095.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.009546435 |
Resistant |
| ENSG00000271086.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.019048245 |
Resistant |
| ENSG00000271732.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.013988198 |
Resistant |
| ENSG00000272070.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.04067313 |
Resistant |
| ENSG00000272183.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.025812532 |
Resistant |
| ENSG00000272198.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.048621689 |
Resistant |
| ENSG00000272369.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.015259298 |
Resistant |
| ENSG00000272377.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.035257029 |
Resistant |
| ENSG00000272403.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.038739004 |
Resistant |
| ENSG00000272905.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.044706407 |
Resistant |
| ENSG00000273076.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.031302514 |
Resistant |
| ENSG00000273381.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.041720586 |
Resistant |
| ENSG00000224511.1 |
Bosutinib |
Brain lower grade glioma |
0.045853627 |
Resistant |
| ENSG00000226194.1 |
Bosutinib |
Brain lower grade glioma |
0.0475095 |
Resistant |
| ENSG00000226349.1 |
Bosutinib |
Brain lower grade glioma |
0.016425636 |
Resistant |
| ENSG00000226445.1 |
Bosutinib |
Brain lower grade glioma |
0.018166582 |
Resistant |
| ENSG00000226798.1 |
Bosutinib |
Brain lower grade glioma |
0.025915244 |
Resistant |
| ENSG00000227082.1 |
Bosutinib |
Brain lower grade glioma |
0.046158308 |
Resistant |
| ENSG00000227218.3 |
Bosutinib |
Brain lower grade glioma |
0.044564137 |
Resistant |
| ENSG00000227407.1 |
Bosutinib |
Brain lower grade glioma |
0.041256778 |
Resistant |
| ENSG00000228444.2 |
Bosutinib |
Brain lower grade glioma |
0.033611595 |
Resistant |
| ENSG00000228784.3 |
Bosutinib |
Brain lower grade glioma |
0.022588633 |
Resistant |
| ENSG00000228798.1 |
Bosutinib |
Brain lower grade glioma |
0.037627631 |
Resistant |
| ENSG00000229983.1 |
Bosutinib |
Brain lower grade glioma |
0.040150496 |
Resistant |
| ENSG00000231121.2 |
Bosutinib |
Brain lower grade glioma |
0.048900583 |
Resistant |
| ENSG00000233452.2 |
Bosutinib |
Brain lower grade glioma |
0.046443661 |
Resistant |
| ENSG00000234617.1 |
Bosutinib |
Brain lower grade glioma |
0.015109354 |
Resistant |
| ENSG00000237234.2 |
Bosutinib |
Brain lower grade glioma |
0.025867955 |
Resistant |
| ENSG00000237640.1 |
Bosutinib |
Brain lower grade glioma |
0.048633637 |
Resistant |
| ENSG00000245812.2 |
Bosutinib |
Brain lower grade glioma |
0.015445463 |
Resistant |
| ENSG00000246662.2 |
Bosutinib |
Brain lower grade glioma |
0.040032796 |
Resistant |
| ENSG00000249685.1 |
Bosutinib |
Brain lower grade glioma |
0.006439238 |
Resistant |
| ENSG00000250001.1 |
Bosutinib |
Brain lower grade glioma |
0.046803077 |
Resistant |
| ENSG00000250240.1 |
Bosutinib |
Brain lower grade glioma |
0.032374435 |
Resistant |
| ENSG00000250508.1 |
Bosutinib |
Brain lower grade glioma |
0.020477298 |
Resistant |
| ENSG00000251370.1 |
Bosutinib |
Brain lower grade glioma |
0.039351239 |
Resistant |
| ENSG00000251613.3 |
Bosutinib |
Brain lower grade glioma |
0.010775548 |
Resistant |
| ENSG00000253591.1 |
Bosutinib |
Brain lower grade glioma |
0.0331813 |
Resistant |
| ENSG00000253973.2 |
Bosutinib |
Brain lower grade glioma |
0.041307754 |
Resistant |
| ENSG00000254539.1 |
Bosutinib |
Brain lower grade glioma |
0.001482715 |
Resistant |
| ENSG00000254731.1 |
Bosutinib |
Brain lower grade glioma |
0.034382796 |
Resistant |
| ENSG00000256025.1 |
Bosutinib |
Brain lower grade glioma |
0.023781581 |
Resistant |
| ENSG00000256237.1 |
Bosutinib |
Brain lower grade glioma |
0.018928732 |
Resistant |
| ENSG00000260396.1 |
Bosutinib |
Brain lower grade glioma |
0.048871977 |
Resistant |
| ENSG00000261291.1 |
Bosutinib |
Brain lower grade glioma |
0.039809823 |
Resistant |
| ENSG00000261534.1 |
Bosutinib |
Brain lower grade glioma |
0.020337039 |
Resistant |
| ENSG00000265752.2 |
Bosutinib |
Brain lower grade glioma |
0.028966855 |
Resistant |
| ENSG00000267397.1 |
Bosutinib |
Brain lower grade glioma |
0.032671019 |
Resistant |
| ENSG00000267414.1 |
Bosutinib |
Brain lower grade glioma |
0.04082734 |
Resistant |
| ENSG00000270022.2 |
Bosutinib |
Brain lower grade glioma |
0.032964346 |
Resistant |
| ENSG00000270093.1 |
Bosutinib |
Brain lower grade glioma |
0.024904121 |
Resistant |
| ENSG00000272024.1 |
Bosutinib |
Brain lower grade glioma |
0.016638468 |
Resistant |
| ENSG00000272091.1 |
Bosutinib |
Brain lower grade glioma |
0.038605949 |
Resistant |
| ENSG00000272796.1 |
Bosutinib |
Brain lower grade glioma |
0.046318549 |
Resistant |
| ENSG00000272823.1 |
Bosutinib |
Brain lower grade glioma |
0.017822589 |
Resistant |
| ENSG00000272914.1 |
Bosutinib |
Brain lower grade glioma |
0.008428161 |
Resistant |
| ENSG00000273287.1 |
Bosutinib |
Brain lower grade glioma |
0.018240008 |
Resistant |
| ENSG00000273289.1 |
Bosutinib |
Brain lower grade glioma |
0.003301864 |
Resistant |
| ENSG00000273476.1 |
Bosutinib |
Brain lower grade glioma |
0.025442958 |
Resistant |
| ENSG00000131484.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.000958957 |
Resistant |
| ENSG00000170161.6 |
Bosutinib |
Lung squamous cell carcinoma |
0.020890948 |
Resistant |
| ENSG00000178248.10 |
Bosutinib |
Lung squamous cell carcinoma |
0.017678279 |
Resistant |
| ENSG00000178947.8 |
Bosutinib |
Lung squamous cell carcinoma |
0.005127748 |
Resistant |
| ENSG00000182873.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.000366483 |
Resistant |
| ENSG00000184068.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.024291166 |
Resistant |
| ENSG00000187621.10 |
Bosutinib |
Lung squamous cell carcinoma |
0.030541974 |
Resistant |
| ENSG00000187979.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.040791982 |
Resistant |
| ENSG00000196273.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.009527051 |
Resistant |
| ENSG00000197291.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.042802535 |
Resistant |
| ENSG00000203288.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.010374032 |
Resistant |
| ENSG00000203729.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.026592527 |
Resistant |
| ENSG00000204241.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.024148302 |
Resistant |
| ENSG00000204666.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.018969807 |
Resistant |
| ENSG00000204802.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.014252569 |
Resistant |
| ENSG00000205181.5 |
Bosutinib |
Lung squamous cell carcinoma |
0.046259623 |
Resistant |
| ENSG00000206028.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04278679 |
Resistant |
| ENSG00000206129.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.037503006 |
Resistant |
| ENSG00000206417.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.003922556 |
Resistant |
| ENSG00000212694.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.034744621 |
Resistant |
| ENSG00000214650.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.003610983 |
Resistant |
| ENSG00000214870.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.040389049 |
Resistant |
| ENSG00000215417.6 |
Bosutinib |
Lung squamous cell carcinoma |
0.00899346 |
Resistant |
| ENSG00000221571.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.020609918 |
Resistant |
| ENSG00000223392.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01709126 |
Resistant |
| ENSG00000223561.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.02247955 |
Resistant |
| ENSG00000223764.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.031054832 |
Resistant |
| ENSG00000223834.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.041382194 |
Resistant |
| ENSG00000223882.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.038001989 |
Resistant |
| ENSG00000223923.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042584313 |
Resistant |
| ENSG00000224189.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.044444831 |
Resistant |
| ENSG00000224358.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00010945 |
Resistant |
| ENSG00000224505.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.008469869 |
Resistant |
| ENSG00000224623.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029243526 |
Resistant |
| ENSG00000224655.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.034653945 |
Resistant |
| ENSG00000224885.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027174763 |
Resistant |
| ENSG00000225234.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.014489945 |
Resistant |
| ENSG00000225278.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.038349938 |
Resistant |
| ENSG00000225528.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.048134495 |
Resistant |
| ENSG00000225559.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.035244117 |
Resistant |
| ENSG00000225783.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.044666885 |
Resistant |
| ENSG00000225792.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024758332 |
Resistant |
| ENSG00000225815.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.034036098 |
Resistant |
| ENSG00000225872.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.024326609 |
Resistant |
| ENSG00000225889.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.009867051 |
Resistant |
| ENSG00000225891.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002102962 |
Resistant |
| ENSG00000225953.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.04005347 |
Resistant |
| ENSG00000226155.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029460372 |
Resistant |
| ENSG00000226352.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.001849869 |
Resistant |
| ENSG00000226453.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.036522113 |
Resistant |
| ENSG00000226819.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045293063 |
Resistant |
| ENSG00000226852.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.039892371 |
Resistant |
| ENSG00000226954.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.018916649 |
Resistant |
| ENSG00000226957.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00517518 |
Resistant |
| ENSG00000227017.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022292307 |
Resistant |
| ENSG00000227094.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.047532026 |
Resistant |
| ENSG00000227188.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.030979986 |
Resistant |
| ENSG00000227248.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03198831 |
Resistant |
| ENSG00000227252.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017357776 |
Resistant |
| ENSG00000227484.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.005974695 |
Resistant |
| ENSG00000227487.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.01958429 |
Resistant |
| ENSG00000227640.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.015101833 |
Resistant |
| ENSG00000227678.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.041112158 |
Resistant |
| ENSG00000227704.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004320211 |
Resistant |
| ENSG00000228079.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.001989987 |
Resistant |
| ENSG00000228141.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.04849541 |
Resistant |
| ENSG00000228271.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.049454986 |
Resistant |
| ENSG00000228274.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.01299282 |
Resistant |
| ENSG00000228382.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.047106872 |
Resistant |
| ENSG00000228485.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008928782 |
Resistant |
| ENSG00000228487.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022783079 |
Resistant |
| ENSG00000228544.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008679514 |
Resistant |
| ENSG00000228697.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033132716 |
Resistant |
| ENSG00000228775.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.045152351 |
Resistant |
| ENSG00000228956.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.041916203 |
Resistant |
| ENSG00000229214.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020184907 |
Resistant |
| ENSG00000229294.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044175302 |
Resistant |
| ENSG00000229312.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.033883434 |
Resistant |
| ENSG00000229323.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02670619 |
Resistant |
| ENSG00000229325.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004989842 |
Resistant |
| ENSG00000229463.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.035014596 |
Resistant |
| ENSG00000229502.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.036867641 |
Resistant |
| ENSG00000229582.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.005916603 |
Resistant |
| ENSG00000229697.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.039282159 |
Resistant |
| ENSG00000229727.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.040280661 |
Resistant |
| ENSG00000229766.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.019613921 |
Resistant |
| ENSG00000229770.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.043962925 |
Resistant |
| ENSG00000229891.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02791659 |
Resistant |
| ENSG00000229970.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.025893385 |
Resistant |
| ENSG00000229996.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033709058 |
Resistant |
| ENSG00000229999.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.017652883 |
Resistant |
| ENSG00000230461.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.030562629 |
Resistant |
| ENSG00000230470.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.018429751 |
Resistant |
| ENSG00000230523.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.036244291 |
Resistant |
| ENSG00000230633.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.003122277 |
Resistant |
| ENSG00000230789.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.012698516 |
Resistant |
| ENSG00000230838.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.043594227 |
Resistant |
| ENSG00000230910.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.03216786 |
Resistant |
| ENSG00000231079.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.013159026 |
Resistant |
| ENSG00000231212.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.034737274 |
Resistant |
| ENSG00000231295.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03183833 |
Resistant |
| ENSG00000231481.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033792821 |
Resistant |
| ENSG00000231654.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01592421 |
Resistant |
| ENSG00000231690.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.028115127 |
Resistant |
| ENSG00000231691.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029026411 |
Resistant |
| ENSG00000231703.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.04356143 |
Resistant |
| ENSG00000232046.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.036306541 |
Resistant |
| ENSG00000232082.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.049474868 |
Resistant |
| ENSG00000232164.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009560649 |
Resistant |
| ENSG00000232192.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.016632859 |
Resistant |
| ENSG00000232300.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00413413 |
Resistant |
| ENSG00000232593.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.02335427 |
Resistant |
| ENSG00000232613.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.004429807 |
Resistant |
| ENSG00000232623.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03973895 |
Resistant |
| ENSG00000232640.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002802006 |
Resistant |
| ENSG00000232645.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02164906 |
Resistant |
| ENSG00000232784.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.036337437 |
Resistant |
| ENSG00000233038.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027393565 |
Resistant |
| ENSG00000233251.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.01978004 |
Resistant |
| ENSG00000233303.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022105401 |
Resistant |
| ENSG00000233367.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.048837537 |
Resistant |
| ENSG00000233427.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044806815 |
Resistant |
| ENSG00000233478.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024122237 |
Resistant |
| ENSG00000233613.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.007585436 |
Resistant |
| ENSG00000233642.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031374155 |
Resistant |
| ENSG00000233800.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.045715504 |
Resistant |
| ENSG00000233806.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.027532084 |
Resistant |
| ENSG00000233885.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.001728861 |
Resistant |
| ENSG00000233942.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.025600287 |
Resistant |
| ENSG00000234006.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000840293 |
Resistant |
| ENSG00000234070.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008978204 |
Resistant |
| ENSG00000234206.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.015734899 |
Resistant |
| ENSG00000234352.5 |
Bosutinib |
Lung squamous cell carcinoma |
0.021830894 |
Resistant |
| ENSG00000234572.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004370563 |
Resistant |
| ENSG00000234715.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009105855 |
Resistant |
| ENSG00000234917.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.038746835 |
Resistant |
| ENSG00000234928.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.028369525 |
Resistant |
| ENSG00000234996.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.037258908 |
Resistant |
| ENSG00000235024.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.046406182 |
Resistant |
| ENSG00000235029.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006923883 |
Resistant |
| ENSG00000235072.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042463535 |
Resistant |
| ENSG00000235077.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.012174602 |
Resistant |
| ENSG00000235121.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.007597111 |
Resistant |
| ENSG00000235366.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.034791867 |
Resistant |
| ENSG00000235659.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029139676 |
Resistant |
| ENSG00000235669.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.015942874 |
Resistant |
| ENSG00000235979.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.037936906 |
Resistant |
| ENSG00000236358.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.030669483 |
Resistant |
| ENSG00000236507.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045208661 |
Resistant |
| ENSG00000236558.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.030342899 |
Resistant |
| ENSG00000236703.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.023001903 |
Resistant |
| ENSG00000236708.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033833572 |
Resistant |
| ENSG00000236711.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.025959159 |
Resistant |
| ENSG00000236772.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013452717 |
Resistant |
| ENSG00000236790.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.035236741 |
Resistant |
| ENSG00000237152.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.007428879 |
Resistant |
| ENSG00000237159.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045014186 |
Resistant |
| ENSG00000237328.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.038497019 |
Resistant |
| ENSG00000237481.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010907581 |
Resistant |
| ENSG00000237594.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.012603226 |
Resistant |
| ENSG00000237658.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020022741 |
Resistant |
| ENSG00000237927.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017986689 |
Resistant |
| ENSG00000237937.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033517449 |
Resistant |
| ENSG00000237940.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.019855775 |
Resistant |
| ENSG00000238197.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.011367568 |
Resistant |
| ENSG00000238221.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010178479 |
Resistant |
| ENSG00000238279.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024836645 |
Resistant |
| ENSG00000239219.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.012944025 |
Resistant |
| ENSG00000239674.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.027640322 |
Resistant |
| ENSG00000240015.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.022333415 |
Resistant |
| ENSG00000240423.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029515238 |
Resistant |
| ENSG00000240591.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029243526 |
Resistant |
| ENSG00000240770.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.037054296 |
Resistant |
| ENSG00000241135.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022820228 |
Resistant |
| ENSG00000241359.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.030694964 |
Resistant |
| ENSG00000241770.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.011666607 |
Resistant |
| ENSG00000241886.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013086374 |
Resistant |
| ENSG00000242540.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.042061665 |
Resistant |
| ENSG00000242770.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.022679514 |
Resistant |
| ENSG00000243810.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.040020149 |
Resistant |
| ENSG00000244124.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006732567 |
Resistant |
| ENSG00000244137.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.035186201 |
Resistant |
| ENSG00000244383.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.046634005 |
Resistant |
| ENSG00000244625.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042253182 |
Resistant |
| ENSG00000245384.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029421119 |
Resistant |
| ENSG00000245870.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.047242115 |
Resistant |
| ENSG00000246430.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.049557768 |
Resistant |
| ENSG00000246465.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.030780867 |
Resistant |
| ENSG00000246528.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.022904379 |
Resistant |
| ENSG00000246790.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.043655666 |
Resistant |
| ENSG00000246851.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024671543 |
Resistant |
| ENSG00000247400.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.001469719 |
Resistant |
| ENSG00000247416.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.041970652 |
Resistant |
| ENSG00000248131.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.015954952 |
Resistant |
| ENSG00000248245.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044142196 |
Resistant |
| ENSG00000248416.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020518678 |
Resistant |
| ENSG00000248445.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.023905853 |
Resistant |
| ENSG00000248528.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03311582 |
Resistant |
| ENSG00000248783.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013948315 |
Resistant |
| ENSG00000249131.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02891035 |
Resistant |
| ENSG00000249167.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031605935 |
Resistant |
| ENSG00000249231.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.014963837 |
Resistant |
| ENSG00000249241.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.043244636 |
Resistant |
| ENSG00000249364.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.043917994 |
Resistant |
| ENSG00000249650.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.012024793 |
Resistant |
| ENSG00000249717.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.019990668 |
Resistant |
| ENSG00000249885.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01750333 |
Resistant |
| ENSG00000250012.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027617017 |
Resistant |
| ENSG00000250043.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033940088 |
Resistant |
| ENSG00000250328.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.037357313 |
Resistant |
| ENSG00000250421.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.025534047 |
Resistant |
| ENSG00000250519.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.017290007 |
Resistant |
| ENSG00000250522.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010780811 |
Resistant |
| ENSG00000250596.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01591996 |
Resistant |
| ENSG00000250699.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010436485 |
Resistant |
| ENSG00000251015.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.032435052 |
Resistant |
| ENSG00000251175.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000298742 |
Resistant |
| ENSG00000251216.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.016010389 |
Resistant |
| ENSG00000251221.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008793471 |
Resistant |
| ENSG00000251301.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.011376751 |
Resistant |
| ENSG00000251363.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.033525331 |
Resistant |
| ENSG00000251387.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024322651 |
Resistant |
| ENSG00000251584.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.047684988 |
Resistant |
| ENSG00000251620.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.037075204 |
Resistant |
| ENSG00000251666.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.001330949 |
Resistant |
| ENSG00000253222.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02218545 |
Resistant |
| ENSG00000253438.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.019174166 |
Resistant |
| ENSG00000253445.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006277749 |
Resistant |
| ENSG00000253477.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013439263 |
Resistant |
| ENSG00000253618.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.011783748 |
Resistant |
| ENSG00000253636.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.001011999 |
Resistant |
| ENSG00000253706.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044288472 |
Resistant |
| ENSG00000253784.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.028296102 |
Resistant |
| ENSG00000253844.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04637867 |
Resistant |
| ENSG00000254044.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04225597 |
Resistant |
| ENSG00000254271.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041320748 |
Resistant |
| ENSG00000254347.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.014496747 |
Resistant |
| ENSG00000254458.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.034078931 |
Resistant |
| ENSG00000254459.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022607246 |
Resistant |
| ENSG00000254484.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.015319236 |
Resistant |
| ENSG00000254557.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03113144 |
Resistant |
| ENSG00000254566.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027624698 |
Resistant |
| ENSG00000254846.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013905671 |
Resistant |
| ENSG00000254864.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017736446 |
Resistant |
| ENSG00000254898.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031914284 |
Resistant |
| ENSG00000254987.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04469488 |
Resistant |
| ENSG00000255435.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.012515918 |
Resistant |
| ENSG00000255467.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.037715576 |
Resistant |
| ENSG00000255580.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.034204913 |
Resistant |
| ENSG00000255670.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041449935 |
Resistant |
| ENSG00000255689.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.034446274 |
Resistant |
| ENSG00000255794.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.036412948 |
Resistant |
| ENSG00000255983.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031117843 |
Resistant |
| ENSG00000256116.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000152611 |
Resistant |
| ENSG00000256146.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045487422 |
Resistant |
| ENSG00000256417.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.026019058 |
Resistant |
| ENSG00000256443.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01604268 |
Resistant |
| ENSG00000256564.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013014177 |
Resistant |
| ENSG00000256746.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004809282 |
Resistant |
| ENSG00000256747.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009575527 |
Resistant |
| ENSG00000256982.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.040993893 |
Resistant |
| ENSG00000256984.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041481868 |
Resistant |
| ENSG00000257002.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.049599386 |
Resistant |
| ENSG00000257023.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.023987211 |
Resistant |
| ENSG00000257366.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020098673 |
Resistant |
| ENSG00000257391.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020208585 |
Resistant |
| ENSG00000257398.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.033248512 |
Resistant |
| ENSG00000257499.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.04610931 |
Resistant |
| ENSG00000257563.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027445624 |
Resistant |
| ENSG00000257613.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.001759742 |
Resistant |
| ENSG00000257696.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.023994152 |
Resistant |
| ENSG00000257769.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04872001 |
Resistant |
| ENSG00000257809.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009568819 |
Resistant |
| ENSG00000257826.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.046673548 |
Resistant |
| ENSG00000258088.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044107817 |
Resistant |
| ENSG00000258123.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017703057 |
Resistant |
| ENSG00000258345.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01354905 |
Resistant |
| ENSG00000258354.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.012048076 |
Resistant |
| ENSG00000258380.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041911302 |
Resistant |
| ENSG00000258412.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02475801 |
Resistant |
| ENSG00000258424.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029772462 |
Resistant |
| ENSG00000258443.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.036393498 |
Resistant |
| ENSG00000258521.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.025531073 |
Resistant |
| ENSG00000258752.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.039446855 |
Resistant |
| ENSG00000258803.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.047626124 |
Resistant |
| ENSG00000258957.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.038384984 |
Resistant |
| ENSG00000259036.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006892277 |
Resistant |
| ENSG00000259039.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.040035605 |
Resistant |
| ENSG00000259073.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.0229294 |
Resistant |
| ENSG00000259084.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.025737278 |
Resistant |
| ENSG00000259129.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.046327395 |
Resistant |
| ENSG00000259135.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006492484 |
Resistant |
| ENSG00000259241.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.034845323 |
Resistant |
| ENSG00000259251.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.027148504 |
Resistant |
| ENSG00000259264.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.040358773 |
Resistant |
| ENSG00000259296.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.005767455 |
Resistant |
| ENSG00000259306.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.042990105 |
Resistant |
| ENSG00000259341.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04273275 |
Resistant |
| ENSG00000259351.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041363244 |
Resistant |
| ENSG00000259377.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04348152 |
Resistant |
| ENSG00000259380.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027351288 |
Resistant |
| ENSG00000259462.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.018550765 |
Resistant |
| ENSG00000259483.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.018323241 |
Resistant |
| ENSG00000259584.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022233062 |
Resistant |
| ENSG00000259594.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.011708487 |
Resistant |
| ENSG00000259598.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.039949551 |
Resistant |
| ENSG00000259666.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020135875 |
Resistant |
| ENSG00000259668.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010041874 |
Resistant |
| ENSG00000259692.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013640062 |
Resistant |
| ENSG00000259701.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027721266 |
Resistant |
| ENSG00000259717.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.049090638 |
Resistant |
| ENSG00000259719.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024090141 |
Resistant |
| ENSG00000259723.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00692238 |
Resistant |
| ENSG00000259725.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042164973 |
Resistant |
| ENSG00000259840.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041599394 |
Resistant |
| ENSG00000259881.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01378505 |
Resistant |
| ENSG00000259935.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008926558 |
Resistant |
| ENSG00000260021.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008145393 |
Resistant |
| ENSG00000260095.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03580091 |
Resistant |
| ENSG00000260167.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03376493 |
Resistant |
| ENSG00000260193.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041547903 |
Resistant |
| ENSG00000260265.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004806999 |
Resistant |
| ENSG00000260293.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.015729115 |
Resistant |
| ENSG00000260296.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009748984 |
Resistant |
| ENSG00000260316.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.021562434 |
Resistant |
| ENSG00000260394.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.0019826 |
Resistant |
| ENSG00000260396.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013950511 |
Resistant |
| ENSG00000260400.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.036776068 |
Resistant |
| ENSG00000260403.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04651839 |
Resistant |
| ENSG00000260418.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017129083 |
Resistant |
| ENSG00000260447.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000770293 |
Resistant |
| ENSG00000260468.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042268419 |
Resistant |
| ENSG00000260517.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.043869864 |
Resistant |
| ENSG00000260565.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.000151006 |
Resistant |
| ENSG00000260572.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000888486 |
Resistant |
| ENSG00000260585.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041161385 |
Resistant |
| ENSG00000260608.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00284765 |
Resistant |
| ENSG00000260614.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041523111 |
Resistant |
| ENSG00000260646.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008288112 |
Resistant |
| ENSG00000260655.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013813968 |
Resistant |
| ENSG00000260660.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01528439 |
Resistant |
| ENSG00000260661.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04535651 |
Resistant |
| ENSG00000260793.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.002365203 |
Resistant |
| ENSG00000260871.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.035063714 |
Resistant |
| ENSG00000260874.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00791635 |
Resistant |
| ENSG00000260930.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.030630741 |
Resistant |
| ENSG00000260931.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031515156 |
Resistant |
| ENSG00000260976.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.049613969 |
Resistant |
| ENSG00000260978.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002790042 |
Resistant |
| ENSG00000261195.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.023692069 |
Resistant |
| ENSG00000261248.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017355126 |
Resistant |
| ENSG00000261265.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.037400875 |
Resistant |
| ENSG00000261416.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002931549 |
Resistant |
| ENSG00000261420.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004214403 |
Resistant |
| ENSG00000261462.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042331226 |
Resistant |
| ENSG00000261474.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.011507086 |
Resistant |
| ENSG00000261496.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022525644 |
Resistant |
| ENSG00000261543.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031626981 |
Resistant |
| ENSG00000261596.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04649197 |
Resistant |
| ENSG00000261713.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.028162077 |
Resistant |
| ENSG00000261720.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031867421 |
Resistant |
| ENSG00000261766.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000749098 |
Resistant |
| ENSG00000262223.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.049872051 |
Resistant |
| ENSG00000262294.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.036170167 |
Resistant |
| ENSG00000262380.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00137208 |
Resistant |
| ENSG00000262558.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045987328 |
Resistant |
| ENSG00000262721.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.032482797 |
Resistant |
| ENSG00000262768.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024554834 |
Resistant |
| ENSG00000262772.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.003437899 |
Resistant |
| ENSG00000262877.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.019163132 |
Resistant |
| ENSG00000263080.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006587393 |
Resistant |
| ENSG00000263499.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017105376 |
Resistant |
| ENSG00000264015.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027200185 |
Resistant |
| ENSG00000264151.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029234856 |
Resistant |
| ENSG00000264167.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.040678847 |
Resistant |
| ENSG00000264207.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03311314 |
Resistant |
| ENSG00000264458.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.021537209 |
Resistant |
| ENSG00000265130.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009563619 |
Resistant |
| ENSG00000265222.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017799831 |
Resistant |
| ENSG00000265342.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00133836 |
Resistant |
| ENSG00000265791.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002980169 |
Resistant |
| ENSG00000265845.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.021528429 |
Resistant |
| ENSG00000266100.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.035061922 |
Resistant |
| ENSG00000266236.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00738524 |
Resistant |
| ENSG00000266256.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.029400846 |
Resistant |
| ENSG00000266312.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.040486106 |
Resistant |
| ENSG00000266918.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004123409 |
Resistant |
| ENSG00000266965.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044651283 |
Resistant |
| ENSG00000267093.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027440685 |
Resistant |
| ENSG00000267161.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.043233964 |
Resistant |
| ENSG00000267167.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033636258 |
Resistant |
| ENSG00000267194.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.018438027 |
Resistant |
| ENSG00000267289.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01750447 |
Resistant |
| ENSG00000267348.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.001960601 |
Resistant |
| ENSG00000267374.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.003841266 |
Resistant |
| ENSG00000267649.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.021457148 |
Resistant |
| ENSG00000267651.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031818397 |
Resistant |
| ENSG00000267659.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.019536088 |
Resistant |
| ENSG00000267667.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.048474433 |
Resistant |
| ENSG00000267677.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02391229 |
Resistant |
| ENSG00000267690.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010509104 |
Resistant |
| ENSG00000268047.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006390519 |
Resistant |
| ENSG00000268307.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017830572 |
Resistant |
| ENSG00000268947.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000719474 |
Resistant |
| ENSG00000269086.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.030508171 |
Resistant |
| ENSG00000269194.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042619944 |
Resistant |
| ENSG00000269489.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000715091 |
Resistant |
| ENSG00000269752.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013144625 |
Resistant |
| ENSG00000269843.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.028457992 |
Resistant |
| ENSG00000269873.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002245762 |
Resistant |
| ENSG00000269911.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004448491 |
Resistant |
| ENSG00000269934.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.046092186 |
Resistant |
| ENSG00000269942.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00631282 |
Resistant |
| ENSG00000269951.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002661152 |
Resistant |
| ENSG00000269978.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04942394 |
Resistant |
| ENSG00000270035.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031253877 |
Resistant |
| ENSG00000270090.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.014962733 |
Resistant |
| ENSG00000270100.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00823621 |
Resistant |
| ENSG00000270104.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020074077 |
Resistant |
| ENSG00000270133.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.014614782 |
Resistant |
| ENSG00000270189.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004305535 |
Resistant |
| ENSG00000270237.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033395891 |
Resistant |
| ENSG00000271109.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02735167 |
Resistant |
| ENSG00000271151.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01289972 |
Resistant |
| ENSG00000271234.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.007932892 |
Resistant |
| ENSG00000271265.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044474732 |
Resistant |
| ENSG00000271314.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027161758 |
Resistant |
| ENSG00000271387.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.038157159 |
Resistant |
| ENSG00000271551.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010923443 |
Resistant |
| ENSG00000271738.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010549737 |
Resistant |
| ENSG00000271757.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.021908358 |
Resistant |
| ENSG00000271803.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.023420788 |
Resistant |
| ENSG00000271830.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024699515 |
Resistant |
| ENSG00000271845.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04533092 |
Resistant |
| ENSG00000271914.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.040864259 |
Resistant |
| ENSG00000271916.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006016884 |
Resistant |
| ENSG00000271938.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017682728 |
Resistant |
| ENSG00000271947.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03101992 |
Resistant |
| ENSG00000271948.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.019075261 |
Resistant |
| ENSG00000271963.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.003647785 |
Resistant |
| ENSG00000272002.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.039057951 |
Resistant |
| ENSG00000272024.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000638361 |
Resistant |
| ENSG00000272033.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.001939279 |
Resistant |
| ENSG00000272048.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.001993175 |
Resistant |
| ENSG00000272076.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.032855306 |
Resistant |
| ENSG00000272167.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01875238 |
Resistant |
| ENSG00000272233.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020467523 |
Resistant |
| ENSG00000272254.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024966227 |
Resistant |
| ENSG00000272301.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00655195 |
Resistant |
| ENSG00000272328.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.019817977 |
Resistant |
| ENSG00000272372.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042967819 |
Resistant |
| ENSG00000272416.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022499199 |
Resistant |
| ENSG00000272425.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004411606 |
Resistant |
| ENSG00000272452.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.019681015 |
Resistant |
| ENSG00000272506.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045623968 |
Resistant |
| ENSG00000272562.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002025424 |
Resistant |
| ENSG00000272632.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.030048196 |
Resistant |
| ENSG00000272672.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.039236569 |
Resistant |
| ENSG00000272677.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.015210812 |
Resistant |
| ENSG00000272717.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000696944 |
Resistant |
| ENSG00000272828.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.049865852 |
Resistant |
| ENSG00000272836.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006994392 |
Resistant |
| ENSG00000272849.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.025393624 |
Resistant |
| ENSG00000272912.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.001457233 |
Resistant |
| ENSG00000272931.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04848292 |
Resistant |
| ENSG00000272940.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002396117 |
Resistant |
| ENSG00000272954.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000358268 |
Resistant |
| ENSG00000272993.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.001604451 |
Resistant |
| ENSG00000273004.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.003440343 |
Resistant |
| ENSG00000273009.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.018592412 |
Resistant |
| ENSG00000273100.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013809685 |
Resistant |
| ENSG00000273156.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.021170198 |
Resistant |
| ENSG00000273253.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00696601 |
Resistant |
| ENSG00000273267.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041514686 |
Resistant |
| ENSG00000273295.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.025909553 |
Resistant |
| ENSG00000273301.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.037355458 |
Resistant |
| ENSG00000273424.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.015259875 |
Resistant |
| ENSG00000180279.5 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.044570928 |
Resistant |
| ENSG00000181800.5 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.008421271 |
Resistant |
| ENSG00000185186.4 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.047455966 |
Resistant |
| ENSG00000189229.10 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.030376294 |
Resistant |
| ENSG00000217258.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.017827497 |
Resistant |
| ENSG00000223804.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.025450107 |
Resistant |
| ENSG00000226445.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.036622454 |
Resistant |
| ENSG00000226856.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.002460427 |
Resistant |
| ENSG00000226869.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.00444346 |
Resistant |
| ENSG00000228624.3 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.011687689 |
Resistant |
| ENSG00000229017.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.015044609 |
Resistant |
| ENSG00000229124.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.044038238 |
Resistant |
| ENSG00000229780.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.011362751 |
Resistant |
| ENSG00000230537.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.042264804 |
Resistant |
| ENSG00000230615.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.019667449 |
Resistant |
| ENSG00000231528.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.044351465 |
Resistant |
| ENSG00000231734.4 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.046289424 |
Resistant |
| ENSG00000233452.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.032916238 |
Resistant |
| ENSG00000233757.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.034643173 |
Resistant |
| ENSG00000234225.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.025325709 |
Resistant |
| ENSG00000234449.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.007199923 |
Resistant |
| ENSG00000235204.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.025794745 |
Resistant |
| ENSG00000235609.4 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.032548357 |
Resistant |
| ENSG00000235831.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.004761606 |
Resistant |
| ENSG00000237813.3 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.033877663 |
Resistant |
| ENSG00000246089.3 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.038122731 |
Resistant |
| ENSG00000249896.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.041423153 |
Resistant |
| ENSG00000254615.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.004888779 |
Resistant |
| ENSG00000254620.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.038105075 |
Resistant |
| ENSG00000254972.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.011955883 |
Resistant |
| ENSG00000255310.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.005845438 |
Resistant |
| ENSG00000258449.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.035068736 |
Resistant |
| ENSG00000260285.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.00902144 |
Resistant |
| ENSG00000260475.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.044300237 |
Resistant |
| ENSG00000260625.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.019314673 |
Resistant |
| ENSG00000260750.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.039092475 |
Resistant |
| ENSG00000261474.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.047330999 |
Resistant |
| ENSG00000261737.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.023662933 |
Resistant |
| ENSG00000262155.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.026892046 |
Resistant |
| ENSG00000262999.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.02596832 |
Resistant |
| ENSG00000264575.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.017603938 |
Resistant |
| ENSG00000265511.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.039369618 |
Resistant |
| ENSG00000267498.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.022219212 |
Resistant |
| ENSG00000267581.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.040099714 |
Resistant |
| ENSG00000267747.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.036336686 |
Resistant |
| ENSG00000268912.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.034005995 |
Resistant |
| ENSG00000269921.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.011371904 |
Resistant |
| ENSG00000270006.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.007911691 |
Resistant |
| ENSG00000271270.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.032278111 |
Resistant |
| ENSG00000272070.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.022147575 |
Resistant |
| ENSG00000273002.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.000107259 |
Resistant |
| ENSG00000185495.6 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046799528 |
Resistant |
| ENSG00000203650.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013967928 |
Resistant |
| ENSG00000203688.4 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027944459 |
Resistant |
| ENSG00000203801.4 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035775164 |
Resistant |
| ENSG00000204706.10 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00341185 |
Resistant |
| ENSG00000204837.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007446639 |
Resistant |
| ENSG00000212978.5 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023224491 |
Resistant |
| ENSG00000213742.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009747904 |
Resistant |
| ENSG00000214146.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032422679 |
Resistant |
| ENSG00000224189.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005696404 |
Resistant |
| ENSG00000224655.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005213623 |
Resistant |
| ENSG00000224969.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040519575 |
Resistant |
| ENSG00000225234.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033206912 |
Resistant |
| ENSG00000225744.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037486601 |
Resistant |
| ENSG00000225850.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001169604 |
Resistant |
| ENSG00000226200.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042670265 |
Resistant |
| ENSG00000226363.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020381808 |
Resistant |
| ENSG00000226416.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042470045 |
Resistant |
| ENSG00000226526.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043829351 |
Resistant |
| ENSG00000227165.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003308993 |
Resistant |
| ENSG00000227637.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005445285 |
Resistant |
| ENSG00000228624.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048886464 |
Resistant |
| ENSG00000228775.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003939127 |
Resistant |
| ENSG00000228784.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040156689 |
Resistant |
| ENSG00000230068.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017068698 |
Resistant |
| ENSG00000230102.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031676772 |
Resistant |
| ENSG00000230310.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023344341 |
Resistant |
| ENSG00000232461.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007330167 |
Resistant |
| ENSG00000232527.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048299168 |
Resistant |
| ENSG00000232969.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038020975 |
Resistant |
| ENSG00000233860.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044783716 |
Resistant |
| ENSG00000234208.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036038935 |
Resistant |
| ENSG00000234286.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031552248 |
Resistant |
| ENSG00000234690.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046699311 |
Resistant |
| ENSG00000235373.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045658665 |
Resistant |
| ENSG00000235706.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037722532 |
Resistant |
| ENSG00000236366.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018784157 |
Resistant |
| ENSG00000236743.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03384251 |
Resistant |
| ENSG00000236824.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030374986 |
Resistant |
| ENSG00000237461.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039588975 |
Resistant |
| ENSG00000240057.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049680458 |
Resistant |
| ENSG00000242622.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045726029 |
Resistant |
| ENSG00000243368.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009918904 |
Resistant |
| ENSG00000243795.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032865582 |
Resistant |
| ENSG00000246250.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025550689 |
Resistant |
| ENSG00000247137.4 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00000841 |
Resistant |
| ENSG00000248092.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016166202 |
Resistant |
| ENSG00000249574.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000813963 |
Resistant |
| ENSG00000250220.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018019642 |
Resistant |
| ENSG00000250413.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036213668 |
Resistant |
| ENSG00000250882.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037008003 |
Resistant |
| ENSG00000253327.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005840072 |
Resistant |
| ENSG00000253931.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043040554 |
Resistant |
| ENSG00000255669.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020965231 |
Resistant |
| ENSG00000257475.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005873558 |
Resistant |
| ENSG00000257964.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03315551 |
Resistant |
| ENSG00000258904.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046878362 |
Resistant |
| ENSG00000259298.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040305303 |
Resistant |
| ENSG00000260008.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011816147 |
Resistant |
| ENSG00000261064.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016927134 |
Resistant |
| ENSG00000261254.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011575126 |
Resistant |
| ENSG00000261842.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013242754 |
Resistant |
| ENSG00000262097.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015434727 |
Resistant |
| ENSG00000262877.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028862753 |
Resistant |
| ENSG00000263657.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023311229 |
Resistant |
| ENSG00000265282.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003141282 |
Resistant |
| ENSG00000265349.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048253653 |
Resistant |
| ENSG00000266446.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027906784 |
Resistant |
| ENSG00000266598.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021671651 |
Resistant |
| ENSG00000266803.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038476553 |
Resistant |
| ENSG00000266904.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048882108 |
Resistant |
| ENSG00000267221.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010482011 |
Resistant |
| ENSG00000267288.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030970314 |
Resistant |
| ENSG00000267560.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031641074 |
Resistant |
| ENSG00000267565.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038389979 |
Resistant |
| ENSG00000267747.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001909747 |
Resistant |
| ENSG00000269086.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001988562 |
Resistant |
| ENSG00000269356.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020719696 |
Resistant |
| ENSG00000269386.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006997098 |
Resistant |
| ENSG00000269463.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0402433 |
Resistant |
| ENSG00000269985.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034347575 |
Resistant |
| ENSG00000269990.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021959008 |
Resistant |
| ENSG00000270010.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016929434 |
Resistant |
| ENSG00000270020.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016350079 |
Resistant |
| ENSG00000270039.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04364704 |
Resistant |
| ENSG00000271717.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012511771 |
Resistant |
| ENSG00000272057.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00934944 |
Resistant |
| ENSG00000272172.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036378853 |
Resistant |
| ENSG00000272248.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039525997 |
Resistant |
| ENSG00000272279.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032070229 |
Resistant |
| ENSG00000272316.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042367834 |
Resistant |
| ENSG00000272699.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041786267 |
Resistant |
| ENSG00000272764.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048349834 |
Resistant |
| ENSG00000273019.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048483818 |
Resistant |
| ENSG00000273374.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031311311 |
Resistant |
| ENSG00000273416.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041224658 |
Resistant |
| ENSG00000226876.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.017814463 |
Resistant |
| ENSG00000227640.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.041773781 |
Resistant |
| ENSG00000228386.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.023360356 |
Resistant |
| ENSG00000229368.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.042857881 |
Resistant |
| ENSG00000233293.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.00483995 |
Resistant |
| ENSG00000234476.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.022298519 |
Resistant |
| ENSG00000246790.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.038722378 |
Resistant |
| ENSG00000250508.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.045767383 |
Resistant |
| ENSG00000251148.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.003659876 |
Resistant |
| ENSG00000254153.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.019706863 |
Resistant |
| ENSG00000254777.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.049936807 |
Resistant |
| ENSG00000255191.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.04033148 |
Resistant |
| ENSG00000258412.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.009607981 |
Resistant |
| ENSG00000258602.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.049675056 |
Resistant |
| ENSG00000267151.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.044850978 |
Resistant |
| ENSG00000267263.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.016509983 |
Resistant |
| ENSG00000272588.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.035827928 |
Resistant |
| ENSG00000224057.1 |
Bosutinib |
Sarcoma |
0.045496946 |
Resistant |
| ENSG00000227438.1 |
Bosutinib |
Sarcoma |
0.018487324 |
Resistant |
| ENSG00000228886.1 |
Bosutinib |
Sarcoma |
0.043535804 |
Resistant |
| ENSG00000229463.2 |
Bosutinib |
Sarcoma |
0.013774511 |
Resistant |
| ENSG00000230131.1 |
Bosutinib |
Sarcoma |
0.039020086 |
Resistant |
| ENSG00000234567.1 |
Bosutinib |
Sarcoma |
0.002248694 |
Resistant |
| ENSG00000235848.2 |
Bosutinib |
Sarcoma |
0.034112328 |
Resistant |
| ENSG00000251131.1 |
Bosutinib |
Sarcoma |
0.014744026 |
Resistant |
| ENSG00000254554.1 |
Bosutinib |
Sarcoma |
0.022006899 |
Resistant |
| ENSG00000261140.1 |
Bosutinib |
Sarcoma |
0.034886464 |
Resistant |
| ENSG00000270571.2 |
Bosutinib |
Sarcoma |
0.027122453 |
Resistant |
| ENSG00000270697.1 |
Bosutinib |
Sarcoma |
0.047935105 |
Resistant |
| ENSG00000272905.1 |
Bosutinib |
Sarcoma |
0.006309324 |
Resistant |
| ENSG00000273307.1 |
Bosutinib |
Sarcoma |
0.013579949 |
Resistant |
| ENSG00000203496.4 |
Bosutinib |
Skin cutaneous melanoma |
0.012974361 |
Resistant |
| ENSG00000205662.2 |
Bosutinib |
Skin cutaneous melanoma |
0.015116793 |
Resistant |
| ENSG00000205663.5 |
Bosutinib |
Skin cutaneous melanoma |
0.02334137 |
Resistant |
| ENSG00000223714.1 |
Bosutinib |
Skin cutaneous melanoma |
0.04832034 |
Resistant |
| ENSG00000224031.1 |
Bosutinib |
Skin cutaneous melanoma |
0.009491915 |
Resistant |
| ENSG00000224157.1 |
Bosutinib |
Skin cutaneous melanoma |
0.02277257 |
Resistant |
| ENSG00000224863.1 |
Bosutinib |
Skin cutaneous melanoma |
0.030117282 |
Resistant |
| ENSG00000224884.1 |
Bosutinib |
Skin cutaneous melanoma |
0.034132626 |
Resistant |
| ENSG00000225063.1 |
Bosutinib |
Skin cutaneous melanoma |
0.045414692 |
Resistant |
| ENSG00000226648.1 |
Bosutinib |
Skin cutaneous melanoma |
0.015458469 |
Resistant |
| ENSG00000226944.1 |
Bosutinib |
Skin cutaneous melanoma |
0.03942567 |
Resistant |
| ENSG00000227740.1 |
Bosutinib |
Skin cutaneous melanoma |
0.007835445 |
Resistant |
| ENSG00000227857.2 |
Bosutinib |
Skin cutaneous melanoma |
0.04315752 |
Resistant |
| ENSG00000228150.1 |
Bosutinib |
Skin cutaneous melanoma |
0.035971761 |
Resistant |
| ENSG00000228386.2 |
Bosutinib |
Skin cutaneous melanoma |
0.023323643 |
Resistant |
| ENSG00000228802.1 |
Bosutinib |
Skin cutaneous melanoma |
0.009975739 |
Resistant |
| ENSG00000229122.1 |
Bosutinib |
Skin cutaneous melanoma |
0.014773495 |
Resistant |
| ENSG00000229348.1 |
Bosutinib |
Skin cutaneous melanoma |
0.019994358 |
Resistant |
| ENSG00000229952.1 |
Bosutinib |
Skin cutaneous melanoma |
0.026313035 |
Resistant |
| ENSG00000230068.2 |
Bosutinib |
Skin cutaneous melanoma |
0.012363174 |
Resistant |
| ENSG00000230815.1 |
Bosutinib |
Skin cutaneous melanoma |
0.03614191 |
Resistant |
| ENSG00000230937.5 |
Bosutinib |
Skin cutaneous melanoma |
0.018598464 |
Resistant |
| ENSG00000231081.1 |
Bosutinib |
Skin cutaneous melanoma |
0.024264816 |
Resistant |
| ENSG00000231297.2 |
Bosutinib |
Skin cutaneous melanoma |
0.007317242 |
Resistant |
| ENSG00000231966.1 |
Bosutinib |
Skin cutaneous melanoma |
0.029995644 |
Resistant |
| ENSG00000232093.1 |
Bosutinib |
Skin cutaneous melanoma |
0.049552705 |
Resistant |
| ENSG00000233351.1 |
Bosutinib |
Skin cutaneous melanoma |
0.020416275 |
Resistant |
| ENSG00000233602.1 |
Bosutinib |
Skin cutaneous melanoma |
0.029131563 |
Resistant |
| ENSG00000233635.2 |
Bosutinib |
Skin cutaneous melanoma |
0.038509058 |
Resistant |
| ENSG00000234943.2 |
Bosutinib |
Skin cutaneous melanoma |
0.048596817 |
Resistant |
| ENSG00000235481.2 |
Bosutinib |
Skin cutaneous melanoma |
0.008422751 |
Resistant |
| ENSG00000235522.2 |
Bosutinib |
Skin cutaneous melanoma |
0.002516565 |
Resistant |
| ENSG00000235770.1 |
Bosutinib |
Skin cutaneous melanoma |
0.03288424 |
Resistant |
| ENSG00000235989.3 |
Bosutinib |
Skin cutaneous melanoma |
0.029714351 |
Resistant |
| ENSG00000236209.1 |
Bosutinib |
Skin cutaneous melanoma |
0.02588022 |
Resistant |
| ENSG00000236617.2 |
Bosutinib |
Skin cutaneous melanoma |
0.020508503 |
Resistant |
| ENSG00000237291.2 |
Bosutinib |
Skin cutaneous melanoma |
0.046873092 |
Resistant |
| ENSG00000237903.1 |
Bosutinib |
Skin cutaneous melanoma |
0.024717998 |
Resistant |
| ENSG00000237989.1 |
Bosutinib |
Skin cutaneous melanoma |
0.036542872 |
Resistant |
| ENSG00000238186.1 |
Bosutinib |
Skin cutaneous melanoma |
0.027000774 |
Resistant |
| ENSG00000238755.3 |
Bosutinib |
Skin cutaneous melanoma |
0.039562188 |
Resistant |
| ENSG00000241912.1 |
Bosutinib |
Skin cutaneous melanoma |
0.022888029 |
Resistant |
| ENSG00000245059.2 |
Bosutinib |
Skin cutaneous melanoma |
0.008070766 |
Resistant |
| ENSG00000245534.2 |
Bosutinib |
Skin cutaneous melanoma |
0.026794943 |
Resistant |
| ENSG00000246339.4 |
Bosutinib |
Skin cutaneous melanoma |
0.005325474 |
Resistant |
| ENSG00000248356.1 |
Bosutinib |
Skin cutaneous melanoma |
0.036957703 |
Resistant |
| ENSG00000248714.2 |
Bosutinib |
Skin cutaneous melanoma |
0.021719023 |
Resistant |
| ENSG00000249650.1 |
Bosutinib |
Skin cutaneous melanoma |
0.029582568 |
Resistant |
| ENSG00000250015.1 |
Bosutinib |
Skin cutaneous melanoma |
0.028283448 |
Resistant |
| ENSG00000250122.1 |
Bosutinib |
Skin cutaneous melanoma |
0.014052431 |
Resistant |
| ENSG00000250312.2 |
Bosutinib |
Skin cutaneous melanoma |
0.032551735 |
Resistant |
| ENSG00000250659.2 |
Bosutinib |
Skin cutaneous melanoma |
0.018020739 |
Resistant |
| ENSG00000250958.1 |
Bosutinib |
Skin cutaneous melanoma |
0.046985934 |
Resistant |
| ENSG00000253317.1 |
Bosutinib |
Skin cutaneous melanoma |
0.018471045 |
Resistant |
| ENSG00000253636.1 |
Bosutinib |
Skin cutaneous melanoma |
0.026273322 |
Resistant |
| ENSG00000254207.1 |
Bosutinib |
Skin cutaneous melanoma |
0.008957686 |
Resistant |
| ENSG00000254370.1 |
Bosutinib |
Skin cutaneous melanoma |
0.042214536 |
Resistant |
| ENSG00000254774.1 |
Bosutinib |
Skin cutaneous melanoma |
0.018456385 |
Resistant |
| ENSG00000255672.1 |
Bosutinib |
Skin cutaneous melanoma |
0.021605089 |
Resistant |
| ENSG00000256458.1 |
Bosutinib |
Skin cutaneous melanoma |
0.004501808 |
Resistant |
| ENSG00000256576.1 |
Bosutinib |
Skin cutaneous melanoma |
0.044696644 |
Resistant |
| ENSG00000258428.1 |
Bosutinib |
Skin cutaneous melanoma |
0.043317466 |
Resistant |
| ENSG00000258593.2 |
Bosutinib |
Skin cutaneous melanoma |
0.038372712 |
Resistant |
| ENSG00000258983.1 |
Bosutinib |
Skin cutaneous melanoma |
0.024714368 |
Resistant |
| ENSG00000259006.1 |
Bosutinib |
Skin cutaneous melanoma |
0.027825809 |
Resistant |
| ENSG00000259584.1 |
Bosutinib |
Skin cutaneous melanoma |
0.037091215 |
Resistant |
| ENSG00000259628.1 |
Bosutinib |
Skin cutaneous melanoma |
0.014202555 |
Resistant |
| ENSG00000260060.1 |
Bosutinib |
Skin cutaneous melanoma |
0.033091513 |
Resistant |
| ENSG00000260306.1 |
Bosutinib |
Skin cutaneous melanoma |
0.036227545 |
Resistant |
| ENSG00000260396.1 |
Bosutinib |
Skin cutaneous melanoma |
0.024211508 |
Resistant |
| ENSG00000260409.1 |
Bosutinib |
Skin cutaneous melanoma |
0.020234194 |
Resistant |
| ENSG00000260455.1 |
Bosutinib |
Skin cutaneous melanoma |
0.043168892 |
Resistant |
| ENSG00000260563.2 |
Bosutinib |
Skin cutaneous melanoma |
0.027956736 |
Resistant |
| ENSG00000260646.1 |
Bosutinib |
Skin cutaneous melanoma |
0.011358955 |
Resistant |
| ENSG00000260790.1 |
Bosutinib |
Skin cutaneous melanoma |
0.017724283 |
Resistant |
| ENSG00000260831.1 |
Bosutinib |
Skin cutaneous melanoma |
0.031642971 |
Resistant |
| ENSG00000260905.1 |
Bosutinib |
Skin cutaneous melanoma |
0.026833413 |
Resistant |
| ENSG00000261033.1 |
Bosutinib |
Skin cutaneous melanoma |
0.039562744 |
Resistant |
| ENSG00000261183.1 |
Bosutinib |
Skin cutaneous melanoma |
0.044503401 |
Resistant |
| ENSG00000261216.1 |
Bosutinib |
Skin cutaneous melanoma |
0.024011183 |
Resistant |
| ENSG00000261334.1 |
Bosutinib |
Skin cutaneous melanoma |
0.005645374 |
Resistant |
| ENSG00000261589.1 |
Bosutinib |
Skin cutaneous melanoma |
0.036312621 |
Resistant |
| ENSG00000261685.2 |
Bosutinib |
Skin cutaneous melanoma |
0.00389706 |
Resistant |
| ENSG00000261879.1 |
Bosutinib |
Skin cutaneous melanoma |
0.027746042 |
Resistant |
| ENSG00000262410.1 |
Bosutinib |
Skin cutaneous melanoma |
0.027469654 |
Resistant |
| ENSG00000263164.1 |
Bosutinib |
Skin cutaneous melanoma |
0.020651541 |
Resistant |
| ENSG00000263603.1 |
Bosutinib |
Skin cutaneous melanoma |
0.012486199 |
Resistant |
| ENSG00000264548.1 |
Bosutinib |
Skin cutaneous melanoma |
0.014569221 |
Resistant |
| ENSG00000264729.1 |
Bosutinib |
Skin cutaneous melanoma |
0.043753942 |
Resistant |
| ENSG00000264940.2 |
Bosutinib |
Skin cutaneous melanoma |
0.02735933 |
Resistant |
| ENSG00000265142.2 |
Bosutinib |
Skin cutaneous melanoma |
0.027557618 |
Resistant |
| ENSG00000265394.1 |
Bosutinib |
Skin cutaneous melanoma |
0.021734163 |
Resistant |
| ENSG00000265791.1 |
Bosutinib |
Skin cutaneous melanoma |
0.005832986 |
Resistant |
| ENSG00000266120.1 |
Bosutinib |
Skin cutaneous melanoma |
0.040443122 |
Resistant |
| ENSG00000266289.1 |
Bosutinib |
Skin cutaneous melanoma |
0.031880942 |
Resistant |
| ENSG00000266340.1 |
Bosutinib |
Skin cutaneous melanoma |
0.018531909 |
Resistant |
| ENSG00000266371.1 |
Bosutinib |
Skin cutaneous melanoma |
0.046752657 |
Resistant |
| ENSG00000266912.1 |
Bosutinib |
Skin cutaneous melanoma |
0.038198209 |
Resistant |
| ENSG00000266935.1 |
Bosutinib |
Skin cutaneous melanoma |
0.028164602 |
Resistant |
| ENSG00000267128.1 |
Bosutinib |
Skin cutaneous melanoma |
0.037945575 |
Resistant |
| ENSG00000267421.2 |
Bosutinib |
Skin cutaneous melanoma |
0.036833103 |
Resistant |
| ENSG00000267481.1 |
Bosutinib |
Skin cutaneous melanoma |
0.002841371 |
Resistant |
| ENSG00000267565.1 |
Bosutinib |
Skin cutaneous melanoma |
0.00299985 |
Resistant |
| ENSG00000267606.1 |
Bosutinib |
Skin cutaneous melanoma |
0.025942587 |
Resistant |
| ENSG00000269463.1 |
Bosutinib |
Skin cutaneous melanoma |
0.00303061 |
Resistant |
| ENSG00000269696.1 |
Bosutinib |
Skin cutaneous melanoma |
0.036830576 |
Resistant |
| ENSG00000269954.1 |
Bosutinib |
Skin cutaneous melanoma |
0.020545272 |
Resistant |
| ENSG00000269956.1 |
Bosutinib |
Skin cutaneous melanoma |
0.018205836 |
Resistant |
| ENSG00000270100.1 |
Bosutinib |
Skin cutaneous melanoma |
0.031896518 |
Resistant |
| ENSG00000270159.1 |
Bosutinib |
Skin cutaneous melanoma |
0.001157308 |
Resistant |
| ENSG00000270361.1 |
Bosutinib |
Skin cutaneous melanoma |
0.015075654 |
Resistant |
| ENSG00000271835.1 |
Bosutinib |
Skin cutaneous melanoma |
0.044659451 |
Resistant |
| ENSG00000271840.1 |
Bosutinib |
Skin cutaneous melanoma |
0.01384 |
Resistant |
| ENSG00000271963.1 |
Bosutinib |
Skin cutaneous melanoma |
0.011302006 |
Resistant |
| ENSG00000271992.1 |
Bosutinib |
Skin cutaneous melanoma |
0.006616626 |
Resistant |
| ENSG00000272065.1 |
Bosutinib |
Skin cutaneous melanoma |
0.013543744 |
Resistant |
| ENSG00000272168.1 |
Bosutinib |
Skin cutaneous melanoma |
0.045233816 |
Resistant |
| ENSG00000272365.1 |
Bosutinib |
Skin cutaneous melanoma |
0.020007969 |
Resistant |
| ENSG00000272384.1 |
Bosutinib |
Skin cutaneous melanoma |
0.046765288 |
Resistant |
| ENSG00000272609.1 |
Bosutinib |
Skin cutaneous melanoma |
0.020581807 |
Resistant |
| ENSG00000272699.1 |
Bosutinib |
Skin cutaneous melanoma |
0.021537907 |
Resistant |
| ENSG00000272942.1 |
Bosutinib |
Skin cutaneous melanoma |
0.042283637 |
Resistant |
| ENSG00000272993.1 |
Bosutinib |
Skin cutaneous melanoma |
0.043039628 |
Resistant |
| ENSG00000273245.1 |
Bosutinib |
Skin cutaneous melanoma |
0.022452024 |
Resistant |
| ENSG00000226505.1 |
Bosutinib |
Stomach adenocarcinoma |
0.038445732 |
Resistant |
| ENSG00000227200.1 |
Bosutinib |
Stomach adenocarcinoma |
0.044535054 |
Resistant |
| ENSG00000234689.1 |
Bosutinib |
Stomach adenocarcinoma |
0.036295871 |
Resistant |
| ENSG00000253392.2 |
Bosutinib |
Stomach adenocarcinoma |
0.031790467 |
Resistant |
| ENSG00000261592.1 |
Bosutinib |
Stomach adenocarcinoma |
0.012535847 |
Resistant |
| ENSG00000203258.3 |
Bosutinib |
Bladder urothelial carcinoma |
0.027038349 |
Sensitive |
| ENSG00000227495.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.016830567 |
Sensitive |
| ENSG00000228470.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.042067566 |
Sensitive |
| ENSG00000229873.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.041398209 |
Sensitive |
| ENSG00000232788.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.037124922 |
Sensitive |
| ENSG00000235214.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.040060679 |
Sensitive |
| ENSG00000239415.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.044312082 |
Sensitive |
| ENSG00000242797.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.028639779 |
Sensitive |
| ENSG00000243321.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.046188335 |
Sensitive |
| ENSG00000251018.2 |
Bosutinib |
Bladder urothelial carcinoma |
0.023600026 |
Sensitive |
| ENSG00000253741.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.029125602 |
Sensitive |
| ENSG00000254433.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.038184523 |
Sensitive |
| ENSG00000255843.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.012851617 |
Sensitive |
| ENSG00000256006.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.043558917 |
Sensitive |
| ENSG00000258424.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.027261792 |
Sensitive |
| ENSG00000259248.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.009823617 |
Sensitive |
| ENSG00000261242.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.022256406 |
Sensitive |
| ENSG00000265908.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.034309535 |
Sensitive |
| ENSG00000267141.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.024471649 |
Sensitive |
| ENSG00000271871.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.043761591 |
Sensitive |
| ENSG00000271966.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.030897934 |
Sensitive |
| ENSG00000272567.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.010815856 |
Sensitive |
| ENSG00000204860.4 |
Bosutinib |
Breast invasive carcinoma |
0.024028728 |
Sensitive |
| ENSG00000206028.1 |
Bosutinib |
Breast invasive carcinoma |
0.024037406 |
Sensitive |
| ENSG00000214803.3 |
Bosutinib |
Breast invasive carcinoma |
0.001691933 |
Sensitive |
| ENSG00000214894.2 |
Bosutinib |
Breast invasive carcinoma |
0.016280671 |
Sensitive |
| ENSG00000215769.4 |
Bosutinib |
Breast invasive carcinoma |
0.009683312 |
Sensitive |
| ENSG00000215841.3 |
Bosutinib |
Breast invasive carcinoma |
0.015334618 |
Sensitive |
| ENSG00000224481.1 |
Bosutinib |
Breast invasive carcinoma |
0.037140473 |
Sensitive |
| ENSG00000224511.1 |
Bosutinib |
Breast invasive carcinoma |
0.03268448 |
Sensitive |
| ENSG00000224565.1 |
Bosutinib |
Breast invasive carcinoma |
0.047367923 |
Sensitive |
| ENSG00000224596.3 |
Bosutinib |
Breast invasive carcinoma |
0.044634447 |
Sensitive |
| ENSG00000224805.2 |
Bosutinib |
Breast invasive carcinoma |
0.020370861 |
Sensitive |
| ENSG00000224818.1 |
Bosutinib |
Breast invasive carcinoma |
0.039898366 |
Sensitive |
| ENSG00000225083.1 |
Bosutinib |
Breast invasive carcinoma |
0.025534513 |
Sensitive |
| ENSG00000225783.2 |
Bosutinib |
Breast invasive carcinoma |
0.016293806 |
Sensitive |
| ENSG00000226051.2 |
Bosutinib |
Breast invasive carcinoma |
0.021302326 |
Sensitive |
| ENSG00000226349.1 |
Bosutinib |
Breast invasive carcinoma |
0.032078713 |
Sensitive |
| ENSG00000226505.1 |
Bosutinib |
Breast invasive carcinoma |
0.035517824 |
Sensitive |
| ENSG00000227589.1 |
Bosutinib |
Breast invasive carcinoma |
0.047718253 |
Sensitive |
| ENSG00000228288.2 |
Bosutinib |
Breast invasive carcinoma |
0.013727307 |
Sensitive |
| ENSG00000230753.1 |
Bosutinib |
Breast invasive carcinoma |
0.045266248 |
Sensitive |
| ENSG00000231054.1 |
Bosutinib |
Breast invasive carcinoma |
0.046226285 |
Sensitive |
| ENSG00000231367.1 |
Bosutinib |
Breast invasive carcinoma |
0.035339259 |
Sensitive |
| ENSG00000231465.2 |
Bosutinib |
Breast invasive carcinoma |
0.044063328 |
Sensitive |
| ENSG00000231898.4 |
Bosutinib |
Breast invasive carcinoma |
0.03926206 |
Sensitive |
| ENSG00000232698.1 |
Bosutinib |
Breast invasive carcinoma |
0.038885199 |
Sensitive |
| ENSG00000233834.2 |
Bosutinib |
Breast invasive carcinoma |
0.037459734 |
Sensitive |
| ENSG00000235726.1 |
Bosutinib |
Breast invasive carcinoma |
0.028084103 |
Sensitive |
| ENSG00000235781.1 |
Bosutinib |
Breast invasive carcinoma |
0.042970712 |
Sensitive |
| ENSG00000237343.1 |
Bosutinib |
Breast invasive carcinoma |
0.013313847 |
Sensitive |
| ENSG00000240005.1 |
Bosutinib |
Breast invasive carcinoma |
0.03532551 |
Sensitive |
| ENSG00000242136.1 |
Bosutinib |
Breast invasive carcinoma |
0.040066659 |
Sensitive |
| ENSG00000245498.2 |
Bosutinib |
Breast invasive carcinoma |
0.020788338 |
Sensitive |
| ENSG00000246740.2 |
Bosutinib |
Breast invasive carcinoma |
0.044686976 |
Sensitive |
| ENSG00000247287.2 |
Bosutinib |
Breast invasive carcinoma |
0.001800248 |
Sensitive |
| ENSG00000247363.2 |
Bosutinib |
Breast invasive carcinoma |
0.039373356 |
Sensitive |
| ENSG00000251687.1 |
Bosutinib |
Breast invasive carcinoma |
0.03632606 |
Sensitive |
| ENSG00000253266.1 |
Bosutinib |
Breast invasive carcinoma |
0.045755662 |
Sensitive |
| ENSG00000254039.1 |
Bosutinib |
Breast invasive carcinoma |
0.011588784 |
Sensitive |
| ENSG00000254286.1 |
Bosutinib |
Breast invasive carcinoma |
0.036622848 |
Sensitive |
| ENSG00000255145.1 |
Bosutinib |
Breast invasive carcinoma |
0.019601113 |
Sensitive |
| ENSG00000255299.1 |
Bosutinib |
Breast invasive carcinoma |
0.032060863 |
Sensitive |
| ENSG00000255318.1 |
Bosutinib |
Breast invasive carcinoma |
0.019590624 |
Sensitive |
| ENSG00000255456.1 |
Bosutinib |
Breast invasive carcinoma |
0.048119322 |
Sensitive |
| ENSG00000257060.2 |
Bosutinib |
Breast invasive carcinoma |
0.042249262 |
Sensitive |
| ENSG00000257084.1 |
Bosutinib |
Breast invasive carcinoma |
0.031318605 |
Sensitive |
| ENSG00000259087.1 |
Bosutinib |
Breast invasive carcinoma |
0.041724991 |
Sensitive |
| ENSG00000259364.1 |
Bosutinib |
Breast invasive carcinoma |
0.041479684 |
Sensitive |
| ENSG00000259579.1 |
Bosutinib |
Breast invasive carcinoma |
0.017591626 |
Sensitive |
| ENSG00000259757.1 |
Bosutinib |
Breast invasive carcinoma |
0.009066353 |
Sensitive |
| ENSG00000260177.1 |
Bosutinib |
Breast invasive carcinoma |
0.026373463 |
Sensitive |
| ENSG00000261000.1 |
Bosutinib |
Breast invasive carcinoma |
0.044467707 |
Sensitive |
| ENSG00000261504.1 |
Bosutinib |
Breast invasive carcinoma |
0.034366577 |
Sensitive |
| ENSG00000261633.1 |
Bosutinib |
Breast invasive carcinoma |
0.046917641 |
Sensitive |
| ENSG00000261656.1 |
Bosutinib |
Breast invasive carcinoma |
0.032110636 |
Sensitive |
| ENSG00000261916.1 |
Bosutinib |
Breast invasive carcinoma |
0.044403012 |
Sensitive |
| ENSG00000264932.2 |
Bosutinib |
Breast invasive carcinoma |
0.032589073 |
Sensitive |
| ENSG00000270988.1 |
Bosutinib |
Breast invasive carcinoma |
0.012646088 |
Sensitive |
| ENSG00000271366.1 |
Bosutinib |
Breast invasive carcinoma |
0.009498655 |
Sensitive |
| ENSG00000272824.1 |
Bosutinib |
Breast invasive carcinoma |
0.04284681 |
Sensitive |
| ENSG00000272933.1 |
Bosutinib |
Breast invasive carcinoma |
0.021798177 |
Sensitive |
| ENSG00000273248.1 |
Bosutinib |
Breast invasive carcinoma |
0.005773056 |
Sensitive |
| ENSG00000214894.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037430375 |
Sensitive |
| ENSG00000233903.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031224638 |
Sensitive |
| ENSG00000234678.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032767993 |
Sensitive |
| ENSG00000235529.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007664972 |
Sensitive |
| ENSG00000237686.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.010101148 |
Sensitive |
| ENSG00000238120.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034458821 |
Sensitive |
| ENSG00000251003.3 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000436135 |
Sensitive |
| ENSG00000258798.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.018821012 |
Sensitive |
| ENSG00000259771.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038475571 |
Sensitive |
| ENSG00000261692.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020644755 |
Sensitive |
| ENSG00000261780.2 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.018963861 |
Sensitive |
| ENSG00000270640.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027939448 |
Sensitive |
| ENSG00000271966.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038663341 |
Sensitive |
| ENSG00000179406.6 |
Bosutinib |
Colon adenocarcinoma |
0.024075573 |
Sensitive |
| ENSG00000223473.1 |
Bosutinib |
Colon adenocarcinoma |
0.010549412 |
Sensitive |
| ENSG00000224142.1 |
Bosutinib |
Colon adenocarcinoma |
0.010059196 |
Sensitive |
| ENSG00000224238.2 |
Bosutinib |
Colon adenocarcinoma |
0.002964351 |
Sensitive |
| ENSG00000225173.1 |
Bosutinib |
Colon adenocarcinoma |
0.042858893 |
Sensitive |
| ENSG00000226200.2 |
Bosutinib |
Colon adenocarcinoma |
0.031320296 |
Sensitive |
| ENSG00000229591.1 |
Bosutinib |
Colon adenocarcinoma |
0.02168206 |
Sensitive |
| ENSG00000229832.1 |
Bosutinib |
Colon adenocarcinoma |
0.018078972 |
Sensitive |
| ENSG00000230427.1 |
Bosutinib |
Colon adenocarcinoma |
0.009677386 |
Sensitive |
| ENSG00000231010.1 |
Bosutinib |
Colon adenocarcinoma |
0.002202953 |
Sensitive |
| ENSG00000232721.1 |
Bosutinib |
Colon adenocarcinoma |
0.008532414 |
Sensitive |
| ENSG00000233847.1 |
Bosutinib |
Colon adenocarcinoma |
0.02625925 |
Sensitive |
| ENSG00000234006.1 |
Bosutinib |
Colon adenocarcinoma |
0.03547577 |
Sensitive |
| ENSG00000234197.1 |
Bosutinib |
Colon adenocarcinoma |
0.007403367 |
Sensitive |
| ENSG00000234456.3 |
Bosutinib |
Colon adenocarcinoma |
0.032940034 |
Sensitive |
| ENSG00000234793.1 |
Bosutinib |
Colon adenocarcinoma |
0.028865812 |
Sensitive |
| ENSG00000236269.1 |
Bosutinib |
Colon adenocarcinoma |
0.043925007 |
Sensitive |
| ENSG00000236394.1 |
Bosutinib |
Colon adenocarcinoma |
0.012146326 |
Sensitive |
| ENSG00000239801.1 |
Bosutinib |
Colon adenocarcinoma |
0.022266434 |
Sensitive |
| ENSG00000239906.1 |
Bosutinib |
Colon adenocarcinoma |
0.021472438 |
Sensitive |
| ENSG00000240401.4 |
Bosutinib |
Colon adenocarcinoma |
0.002069952 |
Sensitive |
| ENSG00000244203.2 |
Bosutinib |
Colon adenocarcinoma |
0.012583161 |
Sensitive |
| ENSG00000245213.2 |
Bosutinib |
Colon adenocarcinoma |
0.031668356 |
Sensitive |
| ENSG00000246090.2 |
Bosutinib |
Colon adenocarcinoma |
0.033763206 |
Sensitive |
| ENSG00000248508.2 |
Bosutinib |
Colon adenocarcinoma |
0.034646341 |
Sensitive |
| ENSG00000249234.1 |
Bosutinib |
Colon adenocarcinoma |
0.024828872 |
Sensitive |
| ENSG00000249664.1 |
Bosutinib |
Colon adenocarcinoma |
0.02261979 |
Sensitive |
| ENSG00000250107.1 |
Bosutinib |
Colon adenocarcinoma |
0.04597636 |
Sensitive |
| ENSG00000250764.1 |
Bosutinib |
Colon adenocarcinoma |
0.019481056 |
Sensitive |
| ENSG00000251279.1 |
Bosutinib |
Colon adenocarcinoma |
0.031013499 |
Sensitive |
| ENSG00000253347.1 |
Bosutinib |
Colon adenocarcinoma |
0.002577552 |
Sensitive |
| ENSG00000253712.1 |
Bosutinib |
Colon adenocarcinoma |
0.022248819 |
Sensitive |
| ENSG00000253744.1 |
Bosutinib |
Colon adenocarcinoma |
0.045384483 |
Sensitive |
| ENSG00000254315.1 |
Bosutinib |
Colon adenocarcinoma |
0.008823658 |
Sensitive |
| ENSG00000256299.1 |
Bosutinib |
Colon adenocarcinoma |
0.019410219 |
Sensitive |
| ENSG00000258443.1 |
Bosutinib |
Colon adenocarcinoma |
0.015888992 |
Sensitive |
| ENSG00000258914.1 |
Bosutinib |
Colon adenocarcinoma |
0.005835661 |
Sensitive |
| ENSG00000259364.1 |
Bosutinib |
Colon adenocarcinoma |
0.038600031 |
Sensitive |
| ENSG00000259418.1 |
Bosutinib |
Colon adenocarcinoma |
0.00826586 |
Sensitive |
| ENSG00000260296.1 |
Bosutinib |
Colon adenocarcinoma |
0.004416813 |
Sensitive |
| ENSG00000260618.1 |
Bosutinib |
Colon adenocarcinoma |
0.003967261 |
Sensitive |
| ENSG00000260655.1 |
Bosutinib |
Colon adenocarcinoma |
0.019897219 |
Sensitive |
| ENSG00000260871.1 |
Bosutinib |
Colon adenocarcinoma |
0.039342457 |
Sensitive |
| ENSG00000261096.1 |
Bosutinib |
Colon adenocarcinoma |
0.043664581 |
Sensitive |
| ENSG00000261430.1 |
Bosutinib |
Colon adenocarcinoma |
0.020847239 |
Sensitive |
| ENSG00000261889.1 |
Bosutinib |
Colon adenocarcinoma |
0.036846343 |
Sensitive |
| ENSG00000263345.1 |
Bosutinib |
Colon adenocarcinoma |
0.013493037 |
Sensitive |
| ENSG00000263603.1 |
Bosutinib |
Colon adenocarcinoma |
0.028861915 |
Sensitive |
| ENSG00000263924.1 |
Bosutinib |
Colon adenocarcinoma |
0.02404256 |
Sensitive |
| ENSG00000264520.1 |
Bosutinib |
Colon adenocarcinoma |
0.002487367 |
Sensitive |
| ENSG00000267317.1 |
Bosutinib |
Colon adenocarcinoma |
0.037861858 |
Sensitive |
| ENSG00000267787.1 |
Bosutinib |
Colon adenocarcinoma |
0.012798807 |
Sensitive |
| ENSG00000270015.1 |
Bosutinib |
Colon adenocarcinoma |
0.003496859 |
Sensitive |
| ENSG00000270140.1 |
Bosutinib |
Colon adenocarcinoma |
0.013018287 |
Sensitive |
| ENSG00000270157.1 |
Bosutinib |
Colon adenocarcinoma |
0.01683954 |
Sensitive |
| ENSG00000270462.1 |
Bosutinib |
Colon adenocarcinoma |
0.026558526 |
Sensitive |
| ENSG00000270589.1 |
Bosutinib |
Colon adenocarcinoma |
0.035964105 |
Sensitive |
| ENSG00000271840.1 |
Bosutinib |
Colon adenocarcinoma |
0.010365763 |
Sensitive |
| ENSG00000271967.1 |
Bosutinib |
Colon adenocarcinoma |
0.004918568 |
Sensitive |
| ENSG00000272040.1 |
Bosutinib |
Colon adenocarcinoma |
0.003577527 |
Sensitive |
| ENSG00000272087.1 |
Bosutinib |
Colon adenocarcinoma |
0.047849275 |
Sensitive |
| ENSG00000272374.1 |
Bosutinib |
Colon adenocarcinoma |
0.018794389 |
Sensitive |
| ENSG00000272622.1 |
Bosutinib |
Colon adenocarcinoma |
0.014164328 |
Sensitive |
| ENSG00000273183.1 |
Bosutinib |
Colon adenocarcinoma |
0.035138172 |
Sensitive |
| ENSG00000177788.5 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030680393 |
Sensitive |
| ENSG00000215863.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024205968 |
Sensitive |
| ENSG00000239664.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031161841 |
Sensitive |
| ENSG00000244300.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017407884 |
Sensitive |
| ENSG00000249593.2 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039676873 |
Sensitive |
| ENSG00000259424.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039795891 |
Sensitive |
| ENSG00000259475.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029760176 |
Sensitive |
| ENSG00000260604.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048265961 |
Sensitive |
| ENSG00000262098.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0474203 |
Sensitive |
| ENSG00000272366.1 |
Bosutinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018190933 |
Sensitive |
| ENSG00000125804.9 |
Bosutinib |
Esophageal cancer |
0.010831389 |
Sensitive |
| ENSG00000171889.3 |
Bosutinib |
Esophageal cancer |
0.016983207 |
Sensitive |
| ENSG00000172965.10 |
Bosutinib |
Esophageal cancer |
0.020131134 |
Sensitive |
| ENSG00000177853.10 |
Bosutinib |
Esophageal cancer |
0.01526634 |
Sensitive |
| ENSG00000179859.7 |
Bosutinib |
Esophageal cancer |
0.025372504 |
Sensitive |
| ENSG00000182165.13 |
Bosutinib |
Esophageal cancer |
0.01943475 |
Sensitive |
| ENSG00000197989.9 |
Bosutinib |
Esophageal cancer |
0.014370429 |
Sensitive |
| ENSG00000203441.2 |
Bosutinib |
Esophageal cancer |
0.028562311 |
Sensitive |
| ENSG00000205622.5 |
Bosutinib |
Esophageal cancer |
0.042989691 |
Sensitive |
| ENSG00000212694.4 |
Bosutinib |
Esophageal cancer |
0.049344481 |
Sensitive |
| ENSG00000215039.2 |
Bosutinib |
Esophageal cancer |
0.025824539 |
Sensitive |
| ENSG00000223461.1 |
Bosutinib |
Esophageal cancer |
0.015440058 |
Sensitive |
| ENSG00000223784.1 |
Bosutinib |
Esophageal cancer |
0.005551134 |
Sensitive |
| ENSG00000224271.1 |
Bosutinib |
Esophageal cancer |
0.004894602 |
Sensitive |
| ENSG00000224614.1 |
Bosutinib |
Esophageal cancer |
0.028119935 |
Sensitive |
| ENSG00000224738.1 |
Bosutinib |
Esophageal cancer |
0.039038905 |
Sensitive |
| ENSG00000224746.1 |
Bosutinib |
Esophageal cancer |
0.030581657 |
Sensitive |
| ENSG00000224888.3 |
Bosutinib |
Esophageal cancer |
0.01193919 |
Sensitive |
| ENSG00000225087.1 |
Bosutinib |
Esophageal cancer |
0.019091847 |
Sensitive |
| ENSG00000225548.1 |
Bosutinib |
Esophageal cancer |
0.043036595 |
Sensitive |
| ENSG00000225703.1 |
Bosutinib |
Esophageal cancer |
0.045681804 |
Sensitive |
| ENSG00000225783.2 |
Bosutinib |
Esophageal cancer |
0.00121793 |
Sensitive |
| ENSG00000226476.2 |
Bosutinib |
Esophageal cancer |
0.043454788 |
Sensitive |
| ENSG00000226562.2 |
Bosutinib |
Esophageal cancer |
0.023755708 |
Sensitive |
| ENSG00000227014.1 |
Bosutinib |
Esophageal cancer |
0.000176745 |
Sensitive |
| ENSG00000227354.2 |
Bosutinib |
Esophageal cancer |
0.044702143 |
Sensitive |
| ENSG00000227403.1 |
Bosutinib |
Esophageal cancer |
0.001073394 |
Sensitive |
| ENSG00000227492.1 |
Bosutinib |
Esophageal cancer |
0.033691805 |
Sensitive |
| ENSG00000227512.1 |
Bosutinib |
Esophageal cancer |
0.033683687 |
Sensitive |
| ENSG00000227627.1 |
Bosutinib |
Esophageal cancer |
0.0398715 |
Sensitive |
| ENSG00000228221.1 |
Bosutinib |
Esophageal cancer |
0.043516399 |
Sensitive |
| ENSG00000228223.1 |
Bosutinib |
Esophageal cancer |
0.036598585 |
Sensitive |
| ENSG00000228274.3 |
Bosutinib |
Esophageal cancer |
0.006039715 |
Sensitive |
| ENSG00000228352.2 |
Bosutinib |
Esophageal cancer |
0.008616574 |
Sensitive |
| ENSG00000228412.2 |
Bosutinib |
Esophageal cancer |
0.034795759 |
Sensitive |
| ENSG00000228470.1 |
Bosutinib |
Esophageal cancer |
0.014465159 |
Sensitive |
| ENSG00000228634.1 |
Bosutinib |
Esophageal cancer |
0.019392443 |
Sensitive |
| ENSG00000228763.1 |
Bosutinib |
Esophageal cancer |
0.015650174 |
Sensitive |
| ENSG00000228886.1 |
Bosutinib |
Esophageal cancer |
0.017248551 |
Sensitive |
| ENSG00000228972.1 |
Bosutinib |
Esophageal cancer |
0.048853657 |
Sensitive |
| ENSG00000229021.2 |
Bosutinib |
Esophageal cancer |
0.030471796 |
Sensitive |
| ENSG00000229832.1 |
Bosutinib |
Esophageal cancer |
0.047095592 |
Sensitive |
| ENSG00000230289.1 |
Bosutinib |
Esophageal cancer |
0.029798767 |
Sensitive |
| ENSG00000230333.2 |
Bosutinib |
Esophageal cancer |
0.034428404 |
Sensitive |
| ENSG00000230912.1 |
Bosutinib |
Esophageal cancer |
0.038100806 |
Sensitive |
| ENSG00000231028.4 |
Bosutinib |
Esophageal cancer |
0.006426788 |
Sensitive |
| ENSG00000231242.1 |
Bosutinib |
Esophageal cancer |
0.003706948 |
Sensitive |
| ENSG00000231407.1 |
Bosutinib |
Esophageal cancer |
0.043904157 |
Sensitive |
| ENSG00000231566.1 |
Bosutinib |
Esophageal cancer |
0.036092828 |
Sensitive |
| ENSG00000231760.2 |
Bosutinib |
Esophageal cancer |
0.017809964 |
Sensitive |
| ENSG00000231816.1 |
Bosutinib |
Esophageal cancer |
0.003456431 |
Sensitive |
| ENSG00000232023.2 |
Bosutinib |
Esophageal cancer |
0.000368121 |
Sensitive |
| ENSG00000232480.1 |
Bosutinib |
Esophageal cancer |
0.024644259 |
Sensitive |
| ENSG00000232618.1 |
Bosutinib |
Esophageal cancer |
0.00662668 |
Sensitive |
| ENSG00000233330.1 |
Bosutinib |
Esophageal cancer |
0.032621236 |
Sensitive |
| ENSG00000233429.5 |
Bosutinib |
Esophageal cancer |
0.022493664 |
Sensitive |
| ENSG00000233654.1 |
Bosutinib |
Esophageal cancer |
0.044710574 |
Sensitive |
| ENSG00000233723.3 |
Bosutinib |
Esophageal cancer |
0.037182495 |
Sensitive |
| ENSG00000233854.1 |
Bosutinib |
Esophageal cancer |
0.049782817 |
Sensitive |
| ENSG00000234384.1 |
Bosutinib |
Esophageal cancer |
0.022059695 |
Sensitive |
| ENSG00000234393.1 |
Bosutinib |
Esophageal cancer |
0.012560875 |
Sensitive |
| ENSG00000234740.1 |
Bosutinib |
Esophageal cancer |
0.011418042 |
Sensitive |
| ENSG00000234997.1 |
Bosutinib |
Esophageal cancer |
0.002903488 |
Sensitive |
| ENSG00000235423.4 |
Bosutinib |
Esophageal cancer |
0.047597511 |
Sensitive |
| ENSG00000235724.4 |
Bosutinib |
Esophageal cancer |
0.032682522 |
Sensitive |
| ENSG00000235790.3 |
Bosutinib |
Esophageal cancer |
0.014429927 |
Sensitive |
| ENSG00000236003.1 |
Bosutinib |
Esophageal cancer |
0.008175655 |
Sensitive |
| ENSG00000236137.1 |
Bosutinib |
Esophageal cancer |
0.02060942 |
Sensitive |
| ENSG00000236269.1 |
Bosutinib |
Esophageal cancer |
0.038745351 |
Sensitive |
| ENSG00000236540.3 |
Bosutinib |
Esophageal cancer |
0.027655165 |
Sensitive |
| ENSG00000236618.2 |
Bosutinib |
Esophageal cancer |
0.03592498 |
Sensitive |
| ENSG00000236751.1 |
Bosutinib |
Esophageal cancer |
0.036148057 |
Sensitive |
| ENSG00000236986.2 |
Bosutinib |
Esophageal cancer |
0.035453948 |
Sensitive |
| ENSG00000237404.1 |
Bosutinib |
Esophageal cancer |
0.045360749 |
Sensitive |
| ENSG00000237753.1 |
Bosutinib |
Esophageal cancer |
0.023579066 |
Sensitive |
| ENSG00000237976.1 |
Bosutinib |
Esophageal cancer |
0.00182303 |
Sensitive |
| ENSG00000238113.2 |
Bosutinib |
Esophageal cancer |
0.030132712 |
Sensitive |
| ENSG00000240207.2 |
Bosutinib |
Esophageal cancer |
0.007072045 |
Sensitive |
| ENSG00000240922.1 |
Bosutinib |
Esophageal cancer |
0.021097991 |
Sensitive |
| ENSG00000242147.1 |
Bosutinib |
Esophageal cancer |
0.0114179 |
Sensitive |
| ENSG00000242474.1 |
Bosutinib |
Esophageal cancer |
0.013492095 |
Sensitive |
| ENSG00000243701.1 |
Bosutinib |
Esophageal cancer |
0.009879347 |
Sensitive |
| ENSG00000244124.1 |
Bosutinib |
Esophageal cancer |
0.019244353 |
Sensitive |
| ENSG00000244300.2 |
Bosutinib |
Esophageal cancer |
0.040000452 |
Sensitive |
| ENSG00000244513.2 |
Bosutinib |
Esophageal cancer |
0.035497018 |
Sensitive |
| ENSG00000244625.1 |
Bosutinib |
Esophageal cancer |
0.004590341 |
Sensitive |
| ENSG00000244945.1 |
Bosutinib |
Esophageal cancer |
0.00922525 |
Sensitive |
| ENSG00000245060.2 |
Bosutinib |
Esophageal cancer |
0.028090573 |
Sensitive |
| ENSG00000245648.1 |
Bosutinib |
Esophageal cancer |
0.016410341 |
Sensitive |
| ENSG00000245711.2 |
Bosutinib |
Esophageal cancer |
0.020772274 |
Sensitive |
| ENSG00000246130.1 |
Bosutinib |
Esophageal cancer |
0.047667292 |
Sensitive |
| ENSG00000246422.2 |
Bosutinib |
Esophageal cancer |
0.006310414 |
Sensitive |
| ENSG00000247572.3 |
Bosutinib |
Esophageal cancer |
0.021897864 |
Sensitive |
| ENSG00000247828.3 |
Bosutinib |
Esophageal cancer |
0.022138099 |
Sensitive |
| ENSG00000247934.3 |
Bosutinib |
Esophageal cancer |
0.038180527 |
Sensitive |
| ENSG00000248240.1 |
Bosutinib |
Esophageal cancer |
0.039679393 |
Sensitive |
| ENSG00000248268.1 |
Bosutinib |
Esophageal cancer |
0.017233277 |
Sensitive |
| ENSG00000248445.1 |
Bosutinib |
Esophageal cancer |
0.001058665 |
Sensitive |
| ENSG00000248554.1 |
Bosutinib |
Esophageal cancer |
0.026218642 |
Sensitive |
| ENSG00000248559.1 |
Bosutinib |
Esophageal cancer |
0.002658298 |
Sensitive |
| ENSG00000248734.2 |
Bosutinib |
Esophageal cancer |
0.008431852 |
Sensitive |
| ENSG00000249042.1 |
Bosutinib |
Esophageal cancer |
0.03224972 |
Sensitive |
| ENSG00000249345.2 |
Bosutinib |
Esophageal cancer |
0.028458012 |
Sensitive |
| ENSG00000249456.1 |
Bosutinib |
Esophageal cancer |
0.043044886 |
Sensitive |
| ENSG00000249492.1 |
Bosutinib |
Esophageal cancer |
0.028546984 |
Sensitive |
| ENSG00000249685.1 |
Bosutinib |
Esophageal cancer |
0.001906687 |
Sensitive |
| ENSG00000250614.1 |
Bosutinib |
Esophageal cancer |
0.019632338 |
Sensitive |
| ENSG00000250682.1 |
Bosutinib |
Esophageal cancer |
0.011068766 |
Sensitive |
| ENSG00000250764.1 |
Bosutinib |
Esophageal cancer |
0.030838976 |
Sensitive |
| ENSG00000250802.2 |
Bosutinib |
Esophageal cancer |
0.029177042 |
Sensitive |
| ENSG00000250909.1 |
Bosutinib |
Esophageal cancer |
0.030062548 |
Sensitive |
| ENSG00000250920.1 |
Bosutinib |
Esophageal cancer |
0.003147211 |
Sensitive |
| ENSG00000251026.1 |
Bosutinib |
Esophageal cancer |
0.006398716 |
Sensitive |
| ENSG00000251194.2 |
Bosutinib |
Esophageal cancer |
0.04954687 |
Sensitive |
| ENSG00000251577.1 |
Bosutinib |
Esophageal cancer |
0.000416786 |
Sensitive |
| ENSG00000251687.1 |
Bosutinib |
Esophageal cancer |
0.036822531 |
Sensitive |
| ENSG00000253392.2 |
Bosutinib |
Esophageal cancer |
0.016693851 |
Sensitive |
| ENSG00000253552.3 |
Bosutinib |
Esophageal cancer |
0.048028797 |
Sensitive |
| ENSG00000254484.1 |
Bosutinib |
Esophageal cancer |
0.025554873 |
Sensitive |
| ENSG00000254495.1 |
Bosutinib |
Esophageal cancer |
0.045731585 |
Sensitive |
| ENSG00000255650.1 |
Bosutinib |
Esophageal cancer |
0.014375182 |
Sensitive |
| ENSG00000255717.2 |
Bosutinib |
Esophageal cancer |
0.024802337 |
Sensitive |
| ENSG00000256146.1 |
Bosutinib |
Esophageal cancer |
0.046614813 |
Sensitive |
| ENSG00000256268.1 |
Bosutinib |
Esophageal cancer |
0.00123228 |
Sensitive |
| ENSG00000256360.1 |
Bosutinib |
Esophageal cancer |
0.032130143 |
Sensitive |
| ENSG00000256417.1 |
Bosutinib |
Esophageal cancer |
0.032804992 |
Sensitive |
| ENSG00000256603.1 |
Bosutinib |
Esophageal cancer |
0.031870706 |
Sensitive |
| ENSG00000256789.1 |
Bosutinib |
Esophageal cancer |
0.033850738 |
Sensitive |
| ENSG00000257052.1 |
Bosutinib |
Esophageal cancer |
0.046716535 |
Sensitive |
| ENSG00000257261.1 |
Bosutinib |
Esophageal cancer |
0.043134884 |
Sensitive |
| ENSG00000257303.1 |
Bosutinib |
Esophageal cancer |
0.047800514 |
Sensitive |
| ENSG00000257354.1 |
Bosutinib |
Esophageal cancer |
0.021480147 |
Sensitive |
| ENSG00000257381.2 |
Bosutinib |
Esophageal cancer |
0.023494677 |
Sensitive |
| ENSG00000257433.1 |
Bosutinib |
Esophageal cancer |
0.03024626 |
Sensitive |
| ENSG00000257475.2 |
Bosutinib |
Esophageal cancer |
0.014101982 |
Sensitive |
| ENSG00000257605.1 |
Bosutinib |
Esophageal cancer |
0.018377896 |
Sensitive |
| ENSG00000257636.2 |
Bosutinib |
Esophageal cancer |
0.005032953 |
Sensitive |
| ENSG00000257742.1 |
Bosutinib |
Esophageal cancer |
0.014269227 |
Sensitive |
| ENSG00000257759.2 |
Bosutinib |
Esophageal cancer |
0.00742321 |
Sensitive |
| ENSG00000257894.1 |
Bosutinib |
Esophageal cancer |
0.003221558 |
Sensitive |
| ENSG00000257999.1 |
Bosutinib |
Esophageal cancer |
0.027528876 |
Sensitive |
| ENSG00000258086.1 |
Bosutinib |
Esophageal cancer |
0.048611875 |
Sensitive |
| ENSG00000258317.1 |
Bosutinib |
Esophageal cancer |
0.035875009 |
Sensitive |
| ENSG00000258378.1 |
Bosutinib |
Esophageal cancer |
0.038937843 |
Sensitive |
| ENSG00000258428.1 |
Bosutinib |
Esophageal cancer |
0.009258944 |
Sensitive |
| ENSG00000258441.1 |
Bosutinib |
Esophageal cancer |
0.0289909 |
Sensitive |
| ENSG00000258454.1 |
Bosutinib |
Esophageal cancer |
0.040376922 |
Sensitive |
| ENSG00000258479.1 |
Bosutinib |
Esophageal cancer |
0.000156545 |
Sensitive |
| ENSG00000258553.1 |
Bosutinib |
Esophageal cancer |
0.029323455 |
Sensitive |
| ENSG00000258580.1 |
Bosutinib |
Esophageal cancer |
0.049214699 |
Sensitive |
| ENSG00000258704.1 |
Bosutinib |
Esophageal cancer |
0.034403848 |
Sensitive |
| ENSG00000258815.1 |
Bosutinib |
Esophageal cancer |
0.010698534 |
Sensitive |
| ENSG00000258983.1 |
Bosutinib |
Esophageal cancer |
0.031137492 |
Sensitive |
| ENSG00000259209.1 |
Bosutinib |
Esophageal cancer |
0.028006594 |
Sensitive |
| ENSG00000259380.1 |
Bosutinib |
Esophageal cancer |
0.043917894 |
Sensitive |
| ENSG00000259426.1 |
Bosutinib |
Esophageal cancer |
0.01055236 |
Sensitive |
| ENSG00000259515.1 |
Bosutinib |
Esophageal cancer |
0.038368991 |
Sensitive |
| ENSG00000259623.1 |
Bosutinib |
Esophageal cancer |
0.043525547 |
Sensitive |
| ENSG00000259768.3 |
Bosutinib |
Esophageal cancer |
0.011435524 |
Sensitive |
| ENSG00000259804.1 |
Bosutinib |
Esophageal cancer |
0.039290197 |
Sensitive |
| ENSG00000259806.2 |
Bosutinib |
Esophageal cancer |
0.035973295 |
Sensitive |
| ENSG00000259828.1 |
Bosutinib |
Esophageal cancer |
0.049192983 |
Sensitive |
| ENSG00000260005.2 |
Bosutinib |
Esophageal cancer |
0.043526594 |
Sensitive |
| ENSG00000260095.1 |
Bosutinib |
Esophageal cancer |
0.022916665 |
Sensitive |
| ENSG00000260136.1 |
Bosutinib |
Esophageal cancer |
0.027317728 |
Sensitive |
| ENSG00000260352.1 |
Bosutinib |
Esophageal cancer |
0.029894154 |
Sensitive |
| ENSG00000260367.1 |
Bosutinib |
Esophageal cancer |
0.006887631 |
Sensitive |
| ENSG00000260664.1 |
Bosutinib |
Esophageal cancer |
0.029173896 |
Sensitive |
| ENSG00000260841.1 |
Bosutinib |
Esophageal cancer |
0.046617558 |
Sensitive |
| ENSG00000260884.1 |
Bosutinib |
Esophageal cancer |
0.032230821 |
Sensitive |
| ENSG00000261008.2 |
Bosutinib |
Esophageal cancer |
0.027708374 |
Sensitive |
| ENSG00000261024.2 |
Bosutinib |
Esophageal cancer |
0.047609424 |
Sensitive |
| ENSG00000261131.1 |
Bosutinib |
Esophageal cancer |
0.016228923 |
Sensitive |
| ENSG00000261140.1 |
Bosutinib |
Esophageal cancer |
0.011276176 |
Sensitive |
| ENSG00000261355.1 |
Bosutinib |
Esophageal cancer |
0.045849995 |
Sensitive |
| ENSG00000261360.1 |
Bosutinib |
Esophageal cancer |
0.030598039 |
Sensitive |
| ENSG00000261505.1 |
Bosutinib |
Esophageal cancer |
0.011539996 |
Sensitive |
| ENSG00000261669.1 |
Bosutinib |
Esophageal cancer |
0.034272858 |
Sensitive |
| ENSG00000261879.1 |
Bosutinib |
Esophageal cancer |
0.041848582 |
Sensitive |
| ENSG00000261996.1 |
Bosutinib |
Esophageal cancer |
0.018515226 |
Sensitive |
| ENSG00000262777.1 |
Bosutinib |
Esophageal cancer |
0.012068817 |
Sensitive |
| ENSG00000263603.1 |
Bosutinib |
Esophageal cancer |
0.033929385 |
Sensitive |
| ENSG00000263786.1 |
Bosutinib |
Esophageal cancer |
0.021553285 |
Sensitive |
| ENSG00000263931.1 |
Bosutinib |
Esophageal cancer |
0.017754954 |
Sensitive |
| ENSG00000264043.2 |
Bosutinib |
Esophageal cancer |
0.028133127 |
Sensitive |
| ENSG00000265222.1 |
Bosutinib |
Esophageal cancer |
0.04538053 |
Sensitive |
| ENSG00000265749.1 |
Bosutinib |
Esophageal cancer |
0.047953632 |
Sensitive |
| ENSG00000267321.1 |
Bosutinib |
Esophageal cancer |
0.041402556 |
Sensitive |
| ENSG00000267583.1 |
Bosutinib |
Esophageal cancer |
0.007160325 |
Sensitive |
| ENSG00000268001.1 |
Bosutinib |
Esophageal cancer |
0.042794053 |
Sensitive |
| ENSG00000268970.1 |
Bosutinib |
Esophageal cancer |
0.031592208 |
Sensitive |
| ENSG00000269235.1 |
Bosutinib |
Esophageal cancer |
0.04428421 |
Sensitive |
| ENSG00000269652.1 |
Bosutinib |
Esophageal cancer |
0.017438097 |
Sensitive |
| ENSG00000269901.1 |
Bosutinib |
Esophageal cancer |
0.030225138 |
Sensitive |
| ENSG00000270067.1 |
Bosutinib |
Esophageal cancer |
0.011836062 |
Sensitive |
| ENSG00000270083.1 |
Bosutinib |
Esophageal cancer |
0.007128071 |
Sensitive |
| ENSG00000270109.1 |
Bosutinib |
Esophageal cancer |
0.03900579 |
Sensitive |
| ENSG00000270117.1 |
Bosutinib |
Esophageal cancer |
0.008710354 |
Sensitive |
| ENSG00000270133.1 |
Bosutinib |
Esophageal cancer |
0.045373045 |
Sensitive |
| ENSG00000270265.1 |
Bosutinib |
Esophageal cancer |
0.014804332 |
Sensitive |
| ENSG00000270562.1 |
Bosutinib |
Esophageal cancer |
0.030801019 |
Sensitive |
| ENSG00000271590.1 |
Bosutinib |
Esophageal cancer |
0.014670181 |
Sensitive |
| ENSG00000271757.1 |
Bosutinib |
Esophageal cancer |
0.0033841 |
Sensitive |
| ENSG00000271789.1 |
Bosutinib |
Esophageal cancer |
0.034136099 |
Sensitive |
| ENSG00000271826.1 |
Bosutinib |
Esophageal cancer |
0.028450493 |
Sensitive |
| ENSG00000271851.1 |
Bosutinib |
Esophageal cancer |
0.03041673 |
Sensitive |
| ENSG00000271862.1 |
Bosutinib |
Esophageal cancer |
0.022363983 |
Sensitive |
| ENSG00000271888.1 |
Bosutinib |
Esophageal cancer |
0.0199397 |
Sensitive |
| ENSG00000272023.1 |
Bosutinib |
Esophageal cancer |
0.006147589 |
Sensitive |
| ENSG00000272040.1 |
Bosutinib |
Esophageal cancer |
0.010830307 |
Sensitive |
| ENSG00000272086.1 |
Bosutinib |
Esophageal cancer |
0.013225689 |
Sensitive |
| ENSG00000272273.1 |
Bosutinib |
Esophageal cancer |
0.023302148 |
Sensitive |
| ENSG00000272327.1 |
Bosutinib |
Esophageal cancer |
0.033011358 |
Sensitive |
| ENSG00000272389.1 |
Bosutinib |
Esophageal cancer |
0.030625326 |
Sensitive |
| ENSG00000272447.1 |
Bosutinib |
Esophageal cancer |
0.036352914 |
Sensitive |
| ENSG00000272452.1 |
Bosutinib |
Esophageal cancer |
0.017096923 |
Sensitive |
| ENSG00000272512.1 |
Bosutinib |
Esophageal cancer |
0.045482761 |
Sensitive |
| ENSG00000272529.1 |
Bosutinib |
Esophageal cancer |
0.040126079 |
Sensitive |
| ENSG00000272558.1 |
Bosutinib |
Esophageal cancer |
0.022656092 |
Sensitive |
| ENSG00000272627.1 |
Bosutinib |
Esophageal cancer |
0.026663272 |
Sensitive |
| ENSG00000272707.1 |
Bosutinib |
Esophageal cancer |
0.01635568 |
Sensitive |
| ENSG00000272995.1 |
Bosutinib |
Esophageal cancer |
0.043033589 |
Sensitive |
| ENSG00000273015.1 |
Bosutinib |
Esophageal cancer |
0.016675751 |
Sensitive |
| ENSG00000273017.1 |
Bosutinib |
Esophageal cancer |
0.049802701 |
Sensitive |
| ENSG00000273218.1 |
Bosutinib |
Esophageal cancer |
0.043234637 |
Sensitive |
| ENSG00000273341.1 |
Bosutinib |
Esophageal cancer |
0.037865643 |
Sensitive |
| ENSG00000273353.1 |
Bosutinib |
Esophageal cancer |
0.029648107 |
Sensitive |
| ENSG00000273384.1 |
Bosutinib |
Esophageal cancer |
0.036880324 |
Sensitive |
| ENSG00000175873.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.019299675 |
Sensitive |
| ENSG00000182165.13 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.039302987 |
Sensitive |
| ENSG00000203356.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.026532115 |
Sensitive |
| ENSG00000203645.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.012727828 |
Sensitive |
| ENSG00000214851.4 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.028882967 |
Sensitive |
| ENSG00000224804.4 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.028812794 |
Sensitive |
| ENSG00000225140.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.005585167 |
Sensitive |
| ENSG00000225265.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.003633811 |
Sensitive |
| ENSG00000226137.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.039406471 |
Sensitive |
| ENSG00000226291.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.028579443 |
Sensitive |
| ENSG00000226330.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.04734015 |
Sensitive |
| ENSG00000226363.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.009988164 |
Sensitive |
| ENSG00000226562.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.039469189 |
Sensitive |
| ENSG00000226754.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.027099251 |
Sensitive |
| ENSG00000226852.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.009864825 |
Sensitive |
| ENSG00000226969.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.045889209 |
Sensitive |
| ENSG00000227542.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.020237327 |
Sensitive |
| ENSG00000228108.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.014828204 |
Sensitive |
| ENSG00000229702.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.042814154 |
Sensitive |
| ENSG00000230020.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.024996149 |
Sensitive |
| ENSG00000231355.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.047665596 |
Sensitive |
| ENSG00000231713.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.008917992 |
Sensitive |
| ENSG00000233363.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.038136403 |
Sensitive |
| ENSG00000234141.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.005590753 |
Sensitive |
| ENSG00000234494.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.016443251 |
Sensitive |
| ENSG00000234678.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.003828807 |
Sensitive |
| ENSG00000234978.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.02275569 |
Sensitive |
| ENSG00000235119.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.0000867 |
Sensitive |
| ENSG00000235335.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.047820574 |
Sensitive |
| ENSG00000235884.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.045181039 |
Sensitive |
| ENSG00000236545.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.016672991 |
Sensitive |
| ENSG00000237149.4 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.014845142 |
Sensitive |
| ENSG00000237380.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.025796311 |
Sensitive |
| ENSG00000237523.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.025699234 |
Sensitive |
| ENSG00000237773.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.041793533 |
Sensitive |
| ENSG00000243479.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.023984835 |
Sensitive |
| ENSG00000245522.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.00486145 |
Sensitive |
| ENSG00000246273.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.022572332 |
Sensitive |
| ENSG00000246898.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.028467065 |
Sensitive |
| ENSG00000248206.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.040940092 |
Sensitive |
| ENSG00000249307.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.006210627 |
Sensitive |
| ENSG00000249610.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.041012467 |
Sensitive |
| ENSG00000250616.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.041352011 |
Sensitive |
| ENSG00000251151.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.046492661 |
Sensitive |
| ENSG00000253552.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.00562172 |
Sensitive |
| ENSG00000253832.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.001292392 |
Sensitive |
| ENSG00000254854.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.03075482 |
Sensitive |
| ENSG00000256312.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.020999493 |
Sensitive |
| ENSG00000257023.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.013024496 |
Sensitive |
| ENSG00000257526.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.000891999 |
Sensitive |
| ENSG00000257702.3 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.044856104 |
Sensitive |
| ENSG00000258821.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.029567311 |
Sensitive |
| ENSG00000259153.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.004741946 |
Sensitive |
| ENSG00000259840.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.033686141 |
Sensitive |
| ENSG00000260018.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.018061905 |
Sensitive |
| ENSG00000260136.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.017599791 |
Sensitive |
| ENSG00000260352.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.042371396 |
Sensitive |
| ENSG00000260643.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.020810223 |
Sensitive |
| ENSG00000261613.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.022652819 |
Sensitive |
| ENSG00000261695.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.015579493 |
Sensitive |
| ENSG00000263105.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.025026371 |
Sensitive |
| ENSG00000263934.2 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.042190928 |
Sensitive |
| ENSG00000264270.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.043371781 |
Sensitive |
| ENSG00000264808.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.036977926 |
Sensitive |
| ENSG00000265349.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.013487034 |
Sensitive |
| ENSG00000265778.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.047824349 |
Sensitive |
| ENSG00000265943.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.001693199 |
Sensitive |
| ENSG00000267010.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.039713948 |
Sensitive |
| ENSG00000267394.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.049309726 |
Sensitive |
| ENSG00000269707.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.006718977 |
Sensitive |
| ENSG00000269976.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.037302043 |
Sensitive |
| ENSG00000270659.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.03086415 |
Sensitive |
| ENSG00000272081.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.025637671 |
Sensitive |
| ENSG00000272892.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.020809064 |
Sensitive |
| ENSG00000273004.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.004125692 |
Sensitive |
| ENSG00000273081.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.048494955 |
Sensitive |
| ENSG00000273492.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.020542494 |
Sensitive |
| ENSG00000246523.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.038611842 |
Sensitive |
| ENSG00000249859.3 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.046897487 |
Sensitive |
| ENSG00000250786.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.023506837 |
Sensitive |
| ENSG00000261353.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.048996473 |
Sensitive |
| ENSG00000262454.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.018591357 |
Sensitive |
| ENSG00000265094.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.0326145 |
Sensitive |
| ENSG00000266709.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.015641345 |
Sensitive |
| ENSG00000270000.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.033657744 |
Sensitive |
| ENSG00000272264.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.028792247 |
Sensitive |
| ENSG00000204380.2 |
Bosutinib |
Brain lower grade glioma |
0.034756702 |
Sensitive |
| ENSG00000224157.1 |
Bosutinib |
Brain lower grade glioma |
0.018288509 |
Sensitive |
| ENSG00000227945.1 |
Bosutinib |
Brain lower grade glioma |
0.016648667 |
Sensitive |
| ENSG00000228540.1 |
Bosutinib |
Brain lower grade glioma |
0.035081461 |
Sensitive |
| ENSG00000230061.1 |
Bosutinib |
Brain lower grade glioma |
0.042046942 |
Sensitive |
| ENSG00000230424.1 |
Bosutinib |
Brain lower grade glioma |
0.028971241 |
Sensitive |
| ENSG00000233501.1 |
Bosutinib |
Brain lower grade glioma |
0.032457012 |
Sensitive |
| ENSG00000233799.1 |
Bosutinib |
Brain lower grade glioma |
0.043983458 |
Sensitive |
| ENSG00000234694.1 |
Bosutinib |
Brain lower grade glioma |
0.04983399 |
Sensitive |
| ENSG00000234902.2 |
Bosutinib |
Brain lower grade glioma |
0.014216134 |
Sensitive |
| ENSG00000235052.1 |
Bosutinib |
Brain lower grade glioma |
0.044484126 |
Sensitive |
| ENSG00000240440.1 |
Bosutinib |
Brain lower grade glioma |
0.018257825 |
Sensitive |
| ENSG00000248125.1 |
Bosutinib |
Brain lower grade glioma |
0.022299442 |
Sensitive |
| ENSG00000249483.1 |
Bosutinib |
Brain lower grade glioma |
0.030334016 |
Sensitive |
| ENSG00000250061.1 |
Bosutinib |
Brain lower grade glioma |
0.044838533 |
Sensitive |
| ENSG00000251307.1 |
Bosutinib |
Brain lower grade glioma |
0.047674411 |
Sensitive |
| ENSG00000251611.1 |
Bosutinib |
Brain lower grade glioma |
0.008535743 |
Sensitive |
| ENSG00000254141.1 |
Bosutinib |
Brain lower grade glioma |
0.04788563 |
Sensitive |
| ENSG00000254389.2 |
Bosutinib |
Brain lower grade glioma |
0.047087387 |
Sensitive |
| ENSG00000254418.1 |
Bosutinib |
Brain lower grade glioma |
0.014269286 |
Sensitive |
| ENSG00000254951.3 |
Bosutinib |
Brain lower grade glioma |
0.042636288 |
Sensitive |
| ENSG00000255237.1 |
Bosutinib |
Brain lower grade glioma |
0.030422878 |
Sensitive |
| ENSG00000255495.1 |
Bosutinib |
Brain lower grade glioma |
0.016610708 |
Sensitive |
| ENSG00000257058.1 |
Bosutinib |
Brain lower grade glioma |
0.037739597 |
Sensitive |
| ENSG00000258952.1 |
Bosutinib |
Brain lower grade glioma |
0.013334209 |
Sensitive |
| ENSG00000259002.1 |
Bosutinib |
Brain lower grade glioma |
0.04605858 |
Sensitive |
| ENSG00000259230.1 |
Bosutinib |
Brain lower grade glioma |
0.045428945 |
Sensitive |
| ENSG00000259514.1 |
Bosutinib |
Brain lower grade glioma |
0.019938595 |
Sensitive |
| ENSG00000259652.1 |
Bosutinib |
Brain lower grade glioma |
0.013190285 |
Sensitive |
| ENSG00000259883.1 |
Bosutinib |
Brain lower grade glioma |
0.040532979 |
Sensitive |
| ENSG00000259915.1 |
Bosutinib |
Brain lower grade glioma |
0.028969382 |
Sensitive |
| ENSG00000260288.2 |
Bosutinib |
Brain lower grade glioma |
0.015176222 |
Sensitive |
| ENSG00000260954.1 |
Bosutinib |
Brain lower grade glioma |
0.049194441 |
Sensitive |
| ENSG00000261329.1 |
Bosutinib |
Brain lower grade glioma |
0.022924828 |
Sensitive |
| ENSG00000261407.1 |
Bosutinib |
Brain lower grade glioma |
0.021945946 |
Sensitive |
| ENSG00000261431.1 |
Bosutinib |
Brain lower grade glioma |
0.011124291 |
Sensitive |
| ENSG00000262171.1 |
Bosutinib |
Brain lower grade glioma |
0.03944909 |
Sensitive |
| ENSG00000262339.1 |
Bosutinib |
Brain lower grade glioma |
0.046138616 |
Sensitive |
| ENSG00000263063.1 |
Bosutinib |
Brain lower grade glioma |
0.0369581 |
Sensitive |
| ENSG00000266126.1 |
Bosutinib |
Brain lower grade glioma |
0.011031654 |
Sensitive |
| ENSG00000266402.2 |
Bosutinib |
Brain lower grade glioma |
0.037315154 |
Sensitive |
| ENSG00000266651.1 |
Bosutinib |
Brain lower grade glioma |
0.034988714 |
Sensitive |
| ENSG00000266941.1 |
Bosutinib |
Brain lower grade glioma |
0.03924297 |
Sensitive |
| ENSG00000267751.1 |
Bosutinib |
Brain lower grade glioma |
0.048095676 |
Sensitive |
| ENSG00000267783.1 |
Bosutinib |
Brain lower grade glioma |
0.019903467 |
Sensitive |
| ENSG00000269906.1 |
Bosutinib |
Brain lower grade glioma |
0.03336569 |
Sensitive |
| ENSG00000270036.1 |
Bosutinib |
Brain lower grade glioma |
0.033823969 |
Sensitive |
| ENSG00000270154.1 |
Bosutinib |
Brain lower grade glioma |
0.041439893 |
Sensitive |
| ENSG00000272265.1 |
Bosutinib |
Brain lower grade glioma |
0.033122408 |
Sensitive |
| ENSG00000272288.1 |
Bosutinib |
Brain lower grade glioma |
0.007759622 |
Sensitive |
| ENSG00000172965.10 |
Bosutinib |
Lung squamous cell carcinoma |
0.0000432 |
Sensitive |
| ENSG00000222041.6 |
Bosutinib |
Lung squamous cell carcinoma |
0.0000396 |
Sensitive |
| ENSG00000223477.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.014510559 |
Sensitive |
| ENSG00000224821.5 |
Bosutinib |
Lung squamous cell carcinoma |
0.031823035 |
Sensitive |
| ENSG00000224932.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.037591985 |
Sensitive |
| ENSG00000224959.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000308266 |
Sensitive |
| ENSG00000225311.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006639039 |
Sensitive |
| ENSG00000225383.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.025196843 |
Sensitive |
| ENSG00000226349.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.016768812 |
Sensitive |
| ENSG00000226375.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008408078 |
Sensitive |
| ENSG00000226520.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009945714 |
Sensitive |
| ENSG00000226842.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.014786959 |
Sensitive |
| ENSG00000227220.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017470397 |
Sensitive |
| ENSG00000227355.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02755863 |
Sensitive |
| ENSG00000227496.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.01088136 |
Sensitive |
| ENSG00000228358.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02486431 |
Sensitive |
| ENSG00000228649.4 |
Bosutinib |
Lung squamous cell carcinoma |
0.001527633 |
Sensitive |
| ENSG00000228707.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04817626 |
Sensitive |
| ENSG00000229951.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041534019 |
Sensitive |
| ENSG00000230109.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041952911 |
Sensitive |
| ENSG00000230499.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.032724405 |
Sensitive |
| ENSG00000230597.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.028036649 |
Sensitive |
| ENSG00000231056.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.047911759 |
Sensitive |
| ENSG00000232325.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.045626815 |
Sensitive |
| ENSG00000232533.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.007231798 |
Sensitive |
| ENSG00000232788.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04838522 |
Sensitive |
| ENSG00000233069.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.016180113 |
Sensitive |
| ENSG00000233237.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.002344198 |
Sensitive |
| ENSG00000233339.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004067468 |
Sensitive |
| ENSG00000233818.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04280778 |
Sensitive |
| ENSG00000235070.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.040211544 |
Sensitive |
| ENSG00000235271.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045084904 |
Sensitive |
| ENSG00000235427.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.000764313 |
Sensitive |
| ENSG00000235927.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.04200139 |
Sensitive |
| ENSG00000236116.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.02285339 |
Sensitive |
| ENSG00000236336.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.046750463 |
Sensitive |
| ENSG00000236643.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.026780577 |
Sensitive |
| ENSG00000236751.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.005542241 |
Sensitive |
| ENSG00000237484.5 |
Bosutinib |
Lung squamous cell carcinoma |
0.035680758 |
Sensitive |
| ENSG00000237714.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045485126 |
Sensitive |
| ENSG00000237813.3 |
Bosutinib |
Lung squamous cell carcinoma |
0.00875789 |
Sensitive |
| ENSG00000237819.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.016956392 |
Sensitive |
| ENSG00000237870.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.042616147 |
Sensitive |
| ENSG00000238266.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042383557 |
Sensitive |
| ENSG00000240006.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045259866 |
Sensitive |
| ENSG00000240093.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.023277947 |
Sensitive |
| ENSG00000240440.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.041611321 |
Sensitive |
| ENSG00000241599.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042217336 |
Sensitive |
| ENSG00000242147.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.049374495 |
Sensitive |
| ENSG00000242391.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.034136081 |
Sensitive |
| ENSG00000242759.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.018730772 |
Sensitive |
| ENSG00000243220.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.046999046 |
Sensitive |
| ENSG00000243636.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03438793 |
Sensitive |
| ENSG00000244158.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.027437663 |
Sensitive |
| ENSG00000244578.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042559721 |
Sensitive |
| ENSG00000246898.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044969603 |
Sensitive |
| ENSG00000248161.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.012119203 |
Sensitive |
| ENSG00000248846.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.044715396 |
Sensitive |
| ENSG00000250106.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.020235713 |
Sensitive |
| ENSG00000250271.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.042995465 |
Sensitive |
| ENSG00000250337.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022532568 |
Sensitive |
| ENSG00000250579.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.044923946 |
Sensitive |
| ENSG00000250961.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.045344871 |
Sensitive |
| ENSG00000251031.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.022717943 |
Sensitive |
| ENSG00000251292.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.019318048 |
Sensitive |
| ENSG00000251442.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010039001 |
Sensitive |
| ENSG00000254002.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.03904795 |
Sensitive |
| ENSG00000254526.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.031923002 |
Sensitive |
| ENSG00000254530.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.039317712 |
Sensitive |
| ENSG00000255375.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.002887562 |
Sensitive |
| ENSG00000256011.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.030990283 |
Sensitive |
| ENSG00000258537.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009730311 |
Sensitive |
| ENSG00000258929.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.048218256 |
Sensitive |
| ENSG00000259005.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.039235953 |
Sensitive |
| ENSG00000259107.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.026923209 |
Sensitive |
| ENSG00000259146.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.019227166 |
Sensitive |
| ENSG00000259370.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.033514519 |
Sensitive |
| ENSG00000259828.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010311255 |
Sensitive |
| ENSG00000261471.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.017805348 |
Sensitive |
| ENSG00000263051.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.016230907 |
Sensitive |
| ENSG00000264222.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.04595561 |
Sensitive |
| ENSG00000266278.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.010380008 |
Sensitive |
| ENSG00000266304.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.037870972 |
Sensitive |
| ENSG00000266927.2 |
Bosutinib |
Lung squamous cell carcinoma |
0.048719869 |
Sensitive |
| ENSG00000267201.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.004315848 |
Sensitive |
| ENSG00000267557.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.046947871 |
Sensitive |
| ENSG00000269019.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.005396263 |
Sensitive |
| ENSG00000269652.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.025164848 |
Sensitive |
| ENSG00000269927.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.025149796 |
Sensitive |
| ENSG00000269966.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.005812256 |
Sensitive |
| ENSG00000271590.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013154989 |
Sensitive |
| ENSG00000271826.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00903956 |
Sensitive |
| ENSG00000272327.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.006394464 |
Sensitive |
| ENSG00000272403.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.009161879 |
Sensitive |
| ENSG00000272695.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.008133926 |
Sensitive |
| ENSG00000272784.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.039735247 |
Sensitive |
| ENSG00000273038.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.024218938 |
Sensitive |
| ENSG00000185904.7 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.030929832 |
Sensitive |
| ENSG00000206028.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.001080476 |
Sensitive |
| ENSG00000224043.3 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.048562832 |
Sensitive |
| ENSG00000225783.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.015744211 |
Sensitive |
| ENSG00000226816.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.012813615 |
Sensitive |
| ENSG00000228107.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.017898552 |
Sensitive |
| ENSG00000230368.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.039352763 |
Sensitive |
| ENSG00000231731.3 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.019632931 |
Sensitive |
| ENSG00000234281.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.016425535 |
Sensitive |
| ENSG00000244586.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.003484249 |
Sensitive |
| ENSG00000244625.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.033992765 |
Sensitive |
| ENSG00000249476.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.045969136 |
Sensitive |
| ENSG00000250049.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.015677956 |
Sensitive |
| ENSG00000250682.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.043337023 |
Sensitive |
| ENSG00000253374.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.044242259 |
Sensitive |
| ENSG00000254144.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.048680402 |
Sensitive |
| ENSG00000257931.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.014976699 |
Sensitive |
| ENSG00000258323.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.008457352 |
Sensitive |
| ENSG00000259349.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.026346849 |
Sensitive |
| ENSG00000259807.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.030561308 |
Sensitive |
| ENSG00000260005.2 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.006716519 |
Sensitive |
| ENSG00000262136.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.005761317 |
Sensitive |
| ENSG00000262265.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.033397976 |
Sensitive |
| ENSG00000265625.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.031572117 |
Sensitive |
| ENSG00000266801.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.034752493 |
Sensitive |
| ENSG00000268568.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.0403023 |
Sensitive |
| ENSG00000270124.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.029402194 |
Sensitive |
| ENSG00000272377.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.01137971 |
Sensitive |
| ENSG00000273265.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.041259658 |
Sensitive |
| ENSG00000179219.5 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015136459 |
Sensitive |
| ENSG00000205662.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037752013 |
Sensitive |
| ENSG00000215692.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04147007 |
Sensitive |
| ENSG00000222041.6 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011136104 |
Sensitive |
| ENSG00000224623.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016776893 |
Sensitive |
| ENSG00000226835.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035893311 |
Sensitive |
| ENSG00000227082.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015780867 |
Sensitive |
| ENSG00000227676.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047362169 |
Sensitive |
| ENSG00000234393.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03889085 |
Sensitive |
| ENSG00000240591.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016776893 |
Sensitive |
| ENSG00000241211.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007561547 |
Sensitive |
| ENSG00000243637.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008851952 |
Sensitive |
| ENSG00000246089.3 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011905946 |
Sensitive |
| ENSG00000246560.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037097629 |
Sensitive |
| ENSG00000254340.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046101974 |
Sensitive |
| ENSG00000254551.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042301514 |
Sensitive |
| ENSG00000254615.2 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036362853 |
Sensitive |
| ENSG00000256006.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047834074 |
Sensitive |
| ENSG00000260651.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019844577 |
Sensitive |
| ENSG00000260708.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017665464 |
Sensitive |
| ENSG00000262339.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019317622 |
Sensitive |
| ENSG00000265399.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034503008 |
Sensitive |
| ENSG00000266579.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003261281 |
Sensitive |
| ENSG00000271722.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002675092 |
Sensitive |
| ENSG00000272688.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049218918 |
Sensitive |
| ENSG00000157306.10 |
Bosutinib |
Pancreatic adenocarcinoma |
0.009071153 |
Sensitive |
| ENSG00000175701.6 |
Bosutinib |
Pancreatic adenocarcinoma |
0.017476416 |
Sensitive |
| ENSG00000175873.3 |
Bosutinib |
Pancreatic adenocarcinoma |
0.04960651 |
Sensitive |
| ENSG00000186615.6 |
Bosutinib |
Pancreatic adenocarcinoma |
0.021838332 |
Sensitive |
| ENSG00000196559.3 |
Bosutinib |
Pancreatic adenocarcinoma |
0.020827684 |
Sensitive |
| ENSG00000203279.3 |
Bosutinib |
Pancreatic adenocarcinoma |
0.009374248 |
Sensitive |
| ENSG00000203999.4 |
Bosutinib |
Pancreatic adenocarcinoma |
0.00517587 |
Sensitive |
| ENSG00000206417.4 |
Bosutinib |
Pancreatic adenocarcinoma |
0.028312009 |
Sensitive |
| ENSG00000223356.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.034219055 |
Sensitive |
| ENSG00000224969.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.005433081 |
Sensitive |
| ENSG00000225235.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.048969685 |
Sensitive |
| ENSG00000225439.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.044400296 |
Sensitive |
| ENSG00000225506.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.002928524 |
Sensitive |
| ENSG00000227888.3 |
Bosutinib |
Pancreatic adenocarcinoma |
0.008118853 |
Sensitive |
| ENSG00000229591.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.032584833 |
Sensitive |
| ENSG00000229839.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.041534148 |
Sensitive |
| ENSG00000230074.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.021682266 |
Sensitive |
| ENSG00000230896.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.00825499 |
Sensitive |
| ENSG00000231050.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.011047537 |
Sensitive |
| ENSG00000231196.3 |
Bosutinib |
Pancreatic adenocarcinoma |
0.025296943 |
Sensitive |
| ENSG00000231305.3 |
Bosutinib |
Pancreatic adenocarcinoma |
0.01698255 |
Sensitive |
| ENSG00000231742.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.03598685 |
Sensitive |
| ENSG00000232160.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.042372238 |
Sensitive |
| ENSG00000232233.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.008505739 |
Sensitive |
| ENSG00000232445.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.037603463 |
Sensitive |
| ENSG00000232956.4 |
Bosutinib |
Pancreatic adenocarcinoma |
0.024526647 |
Sensitive |
| ENSG00000233016.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.031438368 |
Sensitive |
| ENSG00000233077.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.003292737 |
Sensitive |
| ENSG00000233184.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.040513114 |
Sensitive |
| ENSG00000234722.3 |
Bosutinib |
Pancreatic adenocarcinoma |
0.009884384 |
Sensitive |
| ENSG00000235106.4 |
Bosutinib |
Pancreatic adenocarcinoma |
0.048603527 |
Sensitive |
| ENSG00000236066.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.002020254 |
Sensitive |
| ENSG00000236558.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.01014552 |
Sensitive |
| ENSG00000236651.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.018965171 |
Sensitive |
| ENSG00000237310.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.037559395 |
Sensitive |
| ENSG00000237424.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.037589335 |
Sensitive |
| ENSG00000237883.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.02941473 |
Sensitive |
| ENSG00000237886.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.024449558 |
Sensitive |
| ENSG00000239498.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.016151388 |
Sensitive |
| ENSG00000241570.4 |
Bosutinib |
Pancreatic adenocarcinoma |
0.043297635 |
Sensitive |
| ENSG00000243479.3 |
Bosutinib |
Pancreatic adenocarcinoma |
0.041832645 |
Sensitive |
| ENSG00000243960.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.008942239 |
Sensitive |
| ENSG00000246130.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.001118827 |
Sensitive |
| ENSG00000246731.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.031624888 |
Sensitive |
| ENSG00000247595.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.027591225 |
Sensitive |
| ENSG00000248554.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.040867847 |
Sensitive |
| ENSG00000250286.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.006201464 |
Sensitive |
| ENSG00000256312.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.010265055 |
Sensitive |
| ENSG00000256576.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.025436162 |
Sensitive |
| ENSG00000257264.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.038572069 |
Sensitive |
| ENSG00000258099.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.042832665 |
Sensitive |
| ENSG00000258857.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.013435395 |
Sensitive |
| ENSG00000259187.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.041349464 |
Sensitive |
| ENSG00000259306.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.015267677 |
Sensitive |
| ENSG00000259623.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.033170368 |
Sensitive |
| ENSG00000259802.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.040372541 |
Sensitive |
| ENSG00000259886.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.043505926 |
Sensitive |
| ENSG00000259891.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.040957852 |
Sensitive |
| ENSG00000260005.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.035845022 |
Sensitive |
| ENSG00000260018.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.014882598 |
Sensitive |
| ENSG00000260060.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.048424489 |
Sensitive |
| ENSG00000260086.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.036005331 |
Sensitive |
| ENSG00000260118.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.048040834 |
Sensitive |
| ENSG00000260388.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.005032929 |
Sensitive |
| ENSG00000260515.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.009441399 |
Sensitive |
| ENSG00000260743.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.021207048 |
Sensitive |
| ENSG00000260766.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.014415786 |
Sensitive |
| ENSG00000260814.2 |
Bosutinib |
Pancreatic adenocarcinoma |
0.00367594 |
Sensitive |
| ENSG00000261252.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.003218859 |
Sensitive |
| ENSG00000262098.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.006259336 |
Sensitive |
| ENSG00000262837.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.019269432 |
Sensitive |
| ENSG00000265971.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.017828069 |
Sensitive |
| ENSG00000267058.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.041551457 |
Sensitive |
| ENSG00000267080.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.043092091 |
Sensitive |
| ENSG00000267150.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.033282143 |
Sensitive |
| ENSG00000267244.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.040501524 |
Sensitive |
| ENSG00000267322.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.032540165 |
Sensitive |
| ENSG00000267480.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.024276472 |
Sensitive |
| ENSG00000267655.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.039979979 |
Sensitive |
| ENSG00000267715.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.036859149 |
Sensitive |
| ENSG00000267798.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.017423881 |
Sensitive |
| ENSG00000268015.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.020016933 |
Sensitive |
| ENSG00000268375.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.043103223 |
Sensitive |
| ENSG00000268836.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.010343606 |
Sensitive |
| ENSG00000269235.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.001837206 |
Sensitive |
| ENSG00000269386.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.011863527 |
Sensitive |
| ENSG00000269867.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.04169424 |
Sensitive |
| ENSG00000269903.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.027526038 |
Sensitive |
| ENSG00000269946.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.042959297 |
Sensitive |
| ENSG00000270081.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.047102838 |
Sensitive |
| ENSG00000270091.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.044459113 |
Sensitive |
| ENSG00000270170.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.026455019 |
Sensitive |
| ENSG00000270673.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.039416138 |
Sensitive |
| ENSG00000271384.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.015379545 |
Sensitive |
| ENSG00000271732.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.021983111 |
Sensitive |
| ENSG00000271755.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.039169251 |
Sensitive |
| ENSG00000271998.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.010842349 |
Sensitive |
| ENSG00000272009.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.015248685 |
Sensitive |
| ENSG00000272172.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.043338555 |
Sensitive |
| ENSG00000272288.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.033166585 |
Sensitive |
| ENSG00000272375.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.037278663 |
Sensitive |
| ENSG00000272702.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.027129992 |
Sensitive |
| ENSG00000272760.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.049387777 |
Sensitive |
| ENSG00000272829.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.03587458 |
Sensitive |
| ENSG00000273181.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.030007207 |
Sensitive |
| ENSG00000273290.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.01381939 |
Sensitive |
| ENSG00000273306.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.026048323 |
Sensitive |
| ENSG00000273355.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.042047027 |
Sensitive |
| ENSG00000273454.1 |
Bosutinib |
Pancreatic adenocarcinoma |
0.03830141 |
Sensitive |
| ENSG00000203588.3 |
Bosutinib |
Sarcoma |
0.03407683 |
Sensitive |
| ENSG00000223462.2 |
Bosutinib |
Sarcoma |
0.042123204 |
Sensitive |
| ENSG00000224846.1 |
Bosutinib |
Sarcoma |
0.04085765 |
Sensitive |
| ENSG00000224934.2 |
Bosutinib |
Sarcoma |
0.025481293 |
Sensitive |
| ENSG00000225235.1 |
Bosutinib |
Sarcoma |
0.000567842 |
Sensitive |
| ENSG00000226833.1 |
Bosutinib |
Sarcoma |
0.023334461 |
Sensitive |
| ENSG00000228037.1 |
Bosutinib |
Sarcoma |
0.031792122 |
Sensitive |
| ENSG00000228172.1 |
Bosutinib |
Sarcoma |
0.006186572 |
Sensitive |
| ENSG00000228293.1 |
Bosutinib |
Sarcoma |
0.028079312 |
Sensitive |
| ENSG00000228397.1 |
Bosutinib |
Sarcoma |
0.022741 |
Sensitive |
| ENSG00000228452.1 |
Bosutinib |
Sarcoma |
0.019122039 |
Sensitive |
| ENSG00000228939.1 |
Bosutinib |
Sarcoma |
0.049687209 |
Sensitive |
| ENSG00000229589.1 |
Bosutinib |
Sarcoma |
0.035059635 |
Sensitive |
| ENSG00000229728.1 |
Bosutinib |
Sarcoma |
0.027671443 |
Sensitive |
| ENSG00000230530.1 |
Bosutinib |
Sarcoma |
0.04809962 |
Sensitive |
| ENSG00000230679.1 |
Bosutinib |
Sarcoma |
0.006941656 |
Sensitive |
| ENSG00000231050.1 |
Bosutinib |
Sarcoma |
0.049387851 |
Sensitive |
| ENSG00000231233.1 |
Bosutinib |
Sarcoma |
0.015525907 |
Sensitive |
| ENSG00000232412.1 |
Bosutinib |
Sarcoma |
0.044336516 |
Sensitive |
| ENSG00000232645.1 |
Bosutinib |
Sarcoma |
0.032558481 |
Sensitive |
| ENSG00000233178.3 |
Bosutinib |
Sarcoma |
0.008723635 |
Sensitive |
| ENSG00000233223.2 |
Bosutinib |
Sarcoma |
0.000653169 |
Sensitive |
| ENSG00000233893.1 |
Bosutinib |
Sarcoma |
0.041461628 |
Sensitive |
| ENSG00000234072.1 |
Bosutinib |
Sarcoma |
0.013423728 |
Sensitive |
| ENSG00000234492.4 |
Bosutinib |
Sarcoma |
0.022229016 |
Sensitive |
| ENSG00000234684.2 |
Bosutinib |
Sarcoma |
0.041690635 |
Sensitive |
| ENSG00000235106.4 |
Bosutinib |
Sarcoma |
0.048056955 |
Sensitive |
| ENSG00000235897.1 |
Bosutinib |
Sarcoma |
0.020755995 |
Sensitive |
| ENSG00000236200.1 |
Bosutinib |
Sarcoma |
0.02533457 |
Sensitive |
| ENSG00000236618.2 |
Bosutinib |
Sarcoma |
0.046442986 |
Sensitive |
| ENSG00000236908.2 |
Bosutinib |
Sarcoma |
0.019662957 |
Sensitive |
| ENSG00000237686.2 |
Bosutinib |
Sarcoma |
0.036419656 |
Sensitive |
| ENSG00000237753.1 |
Bosutinib |
Sarcoma |
0.032839464 |
Sensitive |
| ENSG00000237852.1 |
Bosutinib |
Sarcoma |
0.04501561 |
Sensitive |
| ENSG00000237899.1 |
Bosutinib |
Sarcoma |
0.045852509 |
Sensitive |
| ENSG00000237940.3 |
Bosutinib |
Sarcoma |
0.048690471 |
Sensitive |
| ENSG00000238113.2 |
Bosutinib |
Sarcoma |
0.002957758 |
Sensitive |
| ENSG00000238221.1 |
Bosutinib |
Sarcoma |
0.027705341 |
Sensitive |
| ENSG00000240291.1 |
Bosutinib |
Sarcoma |
0.044270808 |
Sensitive |
| ENSG00000241933.1 |
Bosutinib |
Sarcoma |
0.025853683 |
Sensitive |
| ENSG00000242516.1 |
Bosutinib |
Sarcoma |
0.0023696 |
Sensitive |
| ENSG00000243224.1 |
Bosutinib |
Sarcoma |
0.025235854 |
Sensitive |
| ENSG00000243926.1 |
Bosutinib |
Sarcoma |
0.026490465 |
Sensitive |
| ENSG00000245556.2 |
Bosutinib |
Sarcoma |
0.003101884 |
Sensitive |
| ENSG00000245849.2 |
Bosutinib |
Sarcoma |
0.038164509 |
Sensitive |
| ENSG00000246889.2 |
Bosutinib |
Sarcoma |
0.013560026 |
Sensitive |
| ENSG00000247240.3 |
Bosutinib |
Sarcoma |
0.003369303 |
Sensitive |
| ENSG00000247516.3 |
Bosutinib |
Sarcoma |
0.023542398 |
Sensitive |
| ENSG00000247595.2 |
Bosutinib |
Sarcoma |
0.024917763 |
Sensitive |
| ENSG00000248925.1 |
Bosutinib |
Sarcoma |
0.022192211 |
Sensitive |
| ENSG00000250734.2 |
Bosutinib |
Sarcoma |
0.013586467 |
Sensitive |
| ENSG00000250751.1 |
Bosutinib |
Sarcoma |
0.013522936 |
Sensitive |
| ENSG00000251323.2 |
Bosutinib |
Sarcoma |
0.042289337 |
Sensitive |
| ENSG00000254266.1 |
Bosutinib |
Sarcoma |
0.034040801 |
Sensitive |
| ENSG00000254538.1 |
Bosutinib |
Sarcoma |
0.022973279 |
Sensitive |
| ENSG00000254985.1 |
Bosutinib |
Sarcoma |
0.039143957 |
Sensitive |
| ENSG00000255031.1 |
Bosutinib |
Sarcoma |
0.03243048 |
Sensitive |
| ENSG00000255234.1 |
Bosutinib |
Sarcoma |
0.001376118 |
Sensitive |
| ENSG00000255337.1 |
Bosutinib |
Sarcoma |
0.042274302 |
Sensitive |
| ENSG00000255507.1 |
Bosutinib |
Sarcoma |
0.029054776 |
Sensitive |
| ENSG00000256006.1 |
Bosutinib |
Sarcoma |
0.026276675 |
Sensitive |
| ENSG00000256588.1 |
Bosutinib |
Sarcoma |
0.024250823 |
Sensitive |
| ENSG00000257058.1 |
Bosutinib |
Sarcoma |
0.024295018 |
Sensitive |
| ENSG00000257964.1 |
Bosutinib |
Sarcoma |
0.026477821 |
Sensitive |
| ENSG00000258057.1 |
Bosutinib |
Sarcoma |
0.04565263 |
Sensitive |
| ENSG00000258099.1 |
Bosutinib |
Sarcoma |
0.03590978 |
Sensitive |
| ENSG00000258730.1 |
Bosutinib |
Sarcoma |
0.047481299 |
Sensitive |
| ENSG00000258940.2 |
Bosutinib |
Sarcoma |
0.019123714 |
Sensitive |
| ENSG00000259087.1 |
Bosutinib |
Sarcoma |
0.021155099 |
Sensitive |
| ENSG00000259469.1 |
Bosutinib |
Sarcoma |
0.03680579 |
Sensitive |
| ENSG00000259577.1 |
Bosutinib |
Sarcoma |
0.036588877 |
Sensitive |
| ENSG00000259687.1 |
Bosutinib |
Sarcoma |
0.00682348 |
Sensitive |
| ENSG00000259744.1 |
Bosutinib |
Sarcoma |
0.007443428 |
Sensitive |
| ENSG00000259943.1 |
Bosutinib |
Sarcoma |
0.012069356 |
Sensitive |
| ENSG00000260141.1 |
Bosutinib |
Sarcoma |
0.036411368 |
Sensitive |
| ENSG00000260209.1 |
Bosutinib |
Sarcoma |
0.002115253 |
Sensitive |
| ENSG00000260526.1 |
Bosutinib |
Sarcoma |
0.019325196 |
Sensitive |
| ENSG00000260954.1 |
Bosutinib |
Sarcoma |
0.027209008 |
Sensitive |
| ENSG00000261188.1 |
Bosutinib |
Sarcoma |
0.011196333 |
Sensitive |
| ENSG00000261334.1 |
Bosutinib |
Sarcoma |
0.038389054 |
Sensitive |
| ENSG00000263214.1 |
Bosutinib |
Sarcoma |
0.004945404 |
Sensitive |
| ENSG00000263884.1 |
Bosutinib |
Sarcoma |
0.025616999 |
Sensitive |
| ENSG00000266942.1 |
Bosutinib |
Sarcoma |
0.017926412 |
Sensitive |
| ENSG00000266957.1 |
Bosutinib |
Sarcoma |
0.017604193 |
Sensitive |
| ENSG00000267348.2 |
Bosutinib |
Sarcoma |
0.037351915 |
Sensitive |
| ENSG00000267940.1 |
Bosutinib |
Sarcoma |
0.013883459 |
Sensitive |
| ENSG00000268061.1 |
Bosutinib |
Sarcoma |
0.04754945 |
Sensitive |
| ENSG00000269487.1 |
Bosutinib |
Sarcoma |
0.03017982 |
Sensitive |
| ENSG00000270049.1 |
Bosutinib |
Sarcoma |
0.027546942 |
Sensitive |
| ENSG00000270076.1 |
Bosutinib |
Sarcoma |
0.025342708 |
Sensitive |
| ENSG00000270159.1 |
Bosutinib |
Sarcoma |
0.022927339 |
Sensitive |
| ENSG00000270557.1 |
Bosutinib |
Sarcoma |
0.025917933 |
Sensitive |
| ENSG00000271151.1 |
Bosutinib |
Sarcoma |
0.021760474 |
Sensitive |
| ENSG00000271335.1 |
Bosutinib |
Sarcoma |
0.003020371 |
Sensitive |
| ENSG00000272128.1 |
Bosutinib |
Sarcoma |
0.016103155 |
Sensitive |
| ENSG00000272273.1 |
Bosutinib |
Sarcoma |
0.049665059 |
Sensitive |
| ENSG00000272562.1 |
Bosutinib |
Sarcoma |
0.032492897 |
Sensitive |
| ENSG00000272567.1 |
Bosutinib |
Sarcoma |
0.042502146 |
Sensitive |
| ENSG00000273015.1 |
Bosutinib |
Sarcoma |
0.0072102 |
Sensitive |
| ENSG00000273145.1 |
Bosutinib |
Sarcoma |
0.032844915 |
Sensitive |
| ENSG00000273474.1 |
Bosutinib |
Sarcoma |
0.009953821 |
Sensitive |
| ENSG00000227297.1 |
Bosutinib |
Skin cutaneous melanoma |
0.02585745 |
Sensitive |
| ENSG00000232692.1 |
Bosutinib |
Skin cutaneous melanoma |
0.032686133 |
Sensitive |
| ENSG00000234263.1 |
Bosutinib |
Skin cutaneous melanoma |
0.040809074 |
Sensitive |
| ENSG00000239219.2 |
Bosutinib |
Skin cutaneous melanoma |
0.04307955 |
Sensitive |
| ENSG00000246526.2 |
Bosutinib |
Skin cutaneous melanoma |
0.003778996 |
Sensitive |
| ENSG00000248668.1 |
Bosutinib |
Skin cutaneous melanoma |
0.033198135 |
Sensitive |
| ENSG00000250786.1 |
Bosutinib |
Skin cutaneous melanoma |
0.038574434 |
Sensitive |
| ENSG00000255008.2 |
Bosutinib |
Skin cutaneous melanoma |
0.010971531 |
Sensitive |
| ENSG00000255299.1 |
Bosutinib |
Skin cutaneous melanoma |
0.040412944 |
Sensitive |
| ENSG00000258413.1 |
Bosutinib |
Skin cutaneous melanoma |
0.03839734 |
Sensitive |
| ENSG00000259125.1 |
Bosutinib |
Skin cutaneous melanoma |
0.039578714 |
Sensitive |
| ENSG00000259606.2 |
Bosutinib |
Skin cutaneous melanoma |
0.021410395 |
Sensitive |
| ENSG00000261357.1 |
Bosutinib |
Skin cutaneous melanoma |
0.049179176 |
Sensitive |
| ENSG00000264448.2 |
Bosutinib |
Skin cutaneous melanoma |
0.033464789 |
Sensitive |
| ENSG00000273165.1 |
Bosutinib |
Skin cutaneous melanoma |
0.034093198 |
Sensitive |
| ENSG00000170161.6 |
Bosutinib |
Stomach adenocarcinoma |
0.043730507 |
Sensitive |
| ENSG00000203588.3 |
Bosutinib |
Stomach adenocarcinoma |
0.026639704 |
Sensitive |
| ENSG00000203650.3 |
Bosutinib |
Stomach adenocarcinoma |
0.007019376 |
Sensitive |
| ENSG00000214293.4 |
Bosutinib |
Stomach adenocarcinoma |
0.046281101 |
Sensitive |
| ENSG00000224975.1 |
Bosutinib |
Stomach adenocarcinoma |
0.023610235 |
Sensitive |
| ENSG00000226380.3 |
Bosutinib |
Stomach adenocarcinoma |
0.047982319 |
Sensitive |
| ENSG00000226862.1 |
Bosutinib |
Stomach adenocarcinoma |
0.031167717 |
Sensitive |
| ENSG00000227006.1 |
Bosutinib |
Stomach adenocarcinoma |
0.041405098 |
Sensitive |
| ENSG00000227773.1 |
Bosutinib |
Stomach adenocarcinoma |
0.044705528 |
Sensitive |
| ENSG00000228043.1 |
Bosutinib |
Stomach adenocarcinoma |
0.015826528 |
Sensitive |
| ENSG00000228506.1 |
Bosutinib |
Stomach adenocarcinoma |
0.013569583 |
Sensitive |
| ENSG00000229952.1 |
Bosutinib |
Stomach adenocarcinoma |
0.024887568 |
Sensitive |
| ENSG00000230433.1 |
Bosutinib |
Stomach adenocarcinoma |
0.01019252 |
Sensitive |
| ENSG00000231709.1 |
Bosutinib |
Stomach adenocarcinoma |
0.046396255 |
Sensitive |
| ENSG00000231711.2 |
Bosutinib |
Stomach adenocarcinoma |
0.01587141 |
Sensitive |
| ENSG00000232082.1 |
Bosutinib |
Stomach adenocarcinoma |
0.045229192 |
Sensitive |
| ENSG00000232104.2 |
Bosutinib |
Stomach adenocarcinoma |
0.049146967 |
Sensitive |
| ENSG00000232118.1 |
Bosutinib |
Stomach adenocarcinoma |
0.005685524 |
Sensitive |
| ENSG00000232342.3 |
Bosutinib |
Stomach adenocarcinoma |
0.026222875 |
Sensitive |
| ENSG00000232936.1 |
Bosutinib |
Stomach adenocarcinoma |
0.048934854 |
Sensitive |
| ENSG00000234405.1 |
Bosutinib |
Stomach adenocarcinoma |
0.005351599 |
Sensitive |
| ENSG00000234695.1 |
Bosutinib |
Stomach adenocarcinoma |
0.000680206 |
Sensitive |
| ENSG00000235078.1 |
Bosutinib |
Stomach adenocarcinoma |
0.009840072 |
Sensitive |
| ENSG00000236088.5 |
Bosutinib |
Stomach adenocarcinoma |
0.019579787 |
Sensitive |
| ENSG00000236199.1 |
Bosutinib |
Stomach adenocarcinoma |
0.015962735 |
Sensitive |
| ENSG00000236861.2 |
Bosutinib |
Stomach adenocarcinoma |
0.031075209 |
Sensitive |
| ENSG00000236914.3 |
Bosutinib |
Stomach adenocarcinoma |
0.008572006 |
Sensitive |
| ENSG00000237152.2 |
Bosutinib |
Stomach adenocarcinoma |
0.023646329 |
Sensitive |
| ENSG00000237605.1 |
Bosutinib |
Stomach adenocarcinoma |
0.012832994 |
Sensitive |
| ENSG00000237786.1 |
Bosutinib |
Stomach adenocarcinoma |
0.029308371 |
Sensitive |
| ENSG00000237903.1 |
Bosutinib |
Stomach adenocarcinoma |
0.001540268 |
Sensitive |
| ENSG00000238009.2 |
Bosutinib |
Stomach adenocarcinoma |
0.001358885 |
Sensitive |
| ENSG00000239945.1 |
Bosutinib |
Stomach adenocarcinoma |
0.002515602 |
Sensitive |
| ENSG00000240571.1 |
Bosutinib |
Stomach adenocarcinoma |
0.012160138 |
Sensitive |
| ENSG00000241288.3 |
Bosutinib |
Stomach adenocarcinoma |
0.048276559 |
Sensitive |
| ENSG00000244968.2 |
Bosutinib |
Stomach adenocarcinoma |
0.044101857 |
Sensitive |
| ENSG00000245573.3 |
Bosutinib |
Stomach adenocarcinoma |
0.039531398 |
Sensitive |
| ENSG00000246225.2 |
Bosutinib |
Stomach adenocarcinoma |
0.017525466 |
Sensitive |
| ENSG00000246898.1 |
Bosutinib |
Stomach adenocarcinoma |
0.033015955 |
Sensitive |
| ENSG00000248896.2 |
Bosutinib |
Stomach adenocarcinoma |
0.000603254 |
Sensitive |
| ENSG00000248936.1 |
Bosutinib |
Stomach adenocarcinoma |
0.016072421 |
Sensitive |
| ENSG00000249417.1 |
Bosutinib |
Stomach adenocarcinoma |
0.014245602 |
Sensitive |
| ENSG00000249898.3 |
Bosutinib |
Stomach adenocarcinoma |
0.035836131 |
Sensitive |
| ENSG00000251026.1 |
Bosutinib |
Stomach adenocarcinoma |
0.025105368 |
Sensitive |
| ENSG00000251323.2 |
Bosutinib |
Stomach adenocarcinoma |
0.002502788 |
Sensitive |
| ENSG00000253307.1 |
Bosutinib |
Stomach adenocarcinoma |
0.000291055 |
Sensitive |
| ENSG00000253955.1 |
Bosutinib |
Stomach adenocarcinoma |
0.020065812 |
Sensitive |
| ENSG00000254731.1 |
Bosutinib |
Stomach adenocarcinoma |
0.044967438 |
Sensitive |
| ENSG00000254791.1 |
Bosutinib |
Stomach adenocarcinoma |
0.001809286 |
Sensitive |
| ENSG00000254966.1 |
Bosutinib |
Stomach adenocarcinoma |
0.048875993 |
Sensitive |
| ENSG00000257004.1 |
Bosutinib |
Stomach adenocarcinoma |
0.03781322 |
Sensitive |
| ENSG00000259198.1 |
Bosutinib |
Stomach adenocarcinoma |
0.035060983 |
Sensitive |
| ENSG00000259345.1 |
Bosutinib |
Stomach adenocarcinoma |
0.038378462 |
Sensitive |
| ENSG00000259380.1 |
Bosutinib |
Stomach adenocarcinoma |
0.04507709 |
Sensitive |
| ENSG00000260037.1 |
Bosutinib |
Stomach adenocarcinoma |
0.010563192 |
Sensitive |
| ENSG00000260360.1 |
Bosutinib |
Stomach adenocarcinoma |
0.04905127 |
Sensitive |
| ENSG00000260368.1 |
Bosutinib |
Stomach adenocarcinoma |
0.032582 |
Sensitive |
| ENSG00000260517.1 |
Bosutinib |
Stomach adenocarcinoma |
0.020729994 |
Sensitive |
| ENSG00000260777.1 |
Bosutinib |
Stomach adenocarcinoma |
0.006382531 |
Sensitive |
| ENSG00000260923.1 |
Bosutinib |
Stomach adenocarcinoma |
0.003949688 |
Sensitive |
| ENSG00000260941.1 |
Bosutinib |
Stomach adenocarcinoma |
0.043014015 |
Sensitive |
| ENSG00000260949.1 |
Bosutinib |
Stomach adenocarcinoma |
0.000380354 |
Sensitive |
| ENSG00000261428.1 |
Bosutinib |
Stomach adenocarcinoma |
0.002902641 |
Sensitive |
| ENSG00000261574.1 |
Bosutinib |
Stomach adenocarcinoma |
0.041286441 |
Sensitive |
| ENSG00000265778.1 |
Bosutinib |
Stomach adenocarcinoma |
0.001640779 |
Sensitive |
| ENSG00000267169.1 |
Bosutinib |
Stomach adenocarcinoma |
0.003835845 |
Sensitive |
| ENSG00000267390.1 |
Bosutinib |
Stomach adenocarcinoma |
0.00558844 |
Sensitive |
| ENSG00000269825.1 |
Bosutinib |
Stomach adenocarcinoma |
0.040037145 |
Sensitive |
| ENSG00000269834.1 |
Bosutinib |
Stomach adenocarcinoma |
0.010820679 |
Sensitive |
| ENSG00000269892.1 |
Bosutinib |
Stomach adenocarcinoma |
0.046573009 |
Sensitive |
| ENSG00000269994.1 |
Bosutinib |
Stomach adenocarcinoma |
0.011006324 |
Sensitive |
| ENSG00000270068.1 |
Bosutinib |
Stomach adenocarcinoma |
0.049026558 |
Sensitive |
| ENSG00000270189.1 |
Bosutinib |
Stomach adenocarcinoma |
0.020570446 |
Sensitive |
| ENSG00000270755.1 |
Bosutinib |
Stomach adenocarcinoma |
0.017292801 |
Sensitive |
| ENSG00000272091.1 |
Bosutinib |
Stomach adenocarcinoma |
0.015928421 |
Sensitive |
| ENSG00000272097.1 |
Bosutinib |
Stomach adenocarcinoma |
0.020640118 |
Sensitive |
| ENSG00000272368.1 |
Bosutinib |
Stomach adenocarcinoma |
0.022009609 |
Sensitive |
| ENSG00000272696.1 |
Bosutinib |
Stomach adenocarcinoma |
0.044248755 |
Sensitive |
| ENSG00000272754.1 |
Bosutinib |
Stomach adenocarcinoma |
0.0000483 |
Sensitive |
| ENSG00000273019.1 |
Bosutinib |
Stomach adenocarcinoma |
0.045155345 |
Sensitive |
